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The placebo effect is a beneficial outcome that follows the administration of a 
treatment and that is not to be ascribed to active ingredients but to the words, 
contexts and beliefs that surround the treatment and that can induce psychological 
and neuronal changes in the recipient’s brain (Benedetti et al., 2011). This 
psychobiological phenomenon represents a good model to study the mind-brain-
body interaction.  
During the past decades, the placebo effect has attracted the interest of researchers 
from different backgrounds, such as psychology, neurobiology, cognitive 
neuroscience among others. Many important studies in the healing context, 
adopting clinical trials or experimental models of pain, have allowed to achieve a 
deep understanding of the neurobiological correlates and cognitive mechanisms 
involved in this phenomenon. In more recent years, however, it has become always 
clearer that the placebo effect is a pervasive phenomenon that extends beyond the 
healing context (Pollo et al., 2011). With regard to this, different lines of evidence 
have shown that the placebo effect can be found in many contexts, such as the 
cognitive, the sensory, the emotional and the motor domains (Beedie & Foad, 2009; 
Beissner et al., 2015; Schienle et al., 2013; Schwarz & Büchel, 2015).  
During my Ph.D. I have been particularly interested in enlarging our knowledge on 
the placebo effect in the motor domain. This interest derives from scientific 
curiosity, as well as from the potential future translational impact of the motor 
placebo effect in sports and pathology. For instance, it could be possible to think at 
the placebo effect as a strategy to implement the outcome obtained with the 
traditional sport trainings and also as a complementary strategy for motor recovery, 
for instance in patients in whom the pharmacological treatment is less effective. 
However, before achieving this translational impact, some issues need to be 
clarified: First, the neural correlates of the placebo effect in the motor domain are 
still largely unknown; Second, knowledge is still limited on the type of motor 
functions that could be influenced by the placebo effect. 
With regard to the first issue, up-to-now very few studies have investigated the 
neural correlates of the motor placebo effect in healthy participants. These studies 
highlighted the role of the primary motor cortex (M1) and the supplementary motor 
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area (SMA) (Fiorio et al., 2014; Piedimonte et al., 2015). Different approaches in 
patients affected by movement disorders, like Parkinson’s disease, hinted at the 
involvement of subcortical structures, like the subtalamic nucleus (STN), the 
substantia nigra pars reticulata (SNr), the ventral anterior (VA) and the anterior 
ventrolateral (VLa) nuclei of the thalamus (Benedetti et al., 2004; Benedetti et al., 
2009). All these brain areas are not isolated, but are strongly connected with other 
brain regions, such as the dorsolateral prefrontal cortex (dlPFC) (Hasan et al., 2013; 
Mayberg et al., 2002; Miller & Cohen, 2001), the cingulate cortex (Asemi et al., 
2015; Mayberg et al., 2002; Petrovic et al., 2002), or the orbitofrontal cortex 
(Petrovic et al., 2002) among others. Of note, these areas have been consistently 
shown to be involved in placebo analgesia (Ashar et al., 2017; Wager & Atlas, 
2015) and it is reasonable to hypothesize that they could also play a role in the 
motor placebo effect. In particular, the dlPFC plays a crucial role in placebo 
analgesia and it is also involved in higher-order cognitive functions, like 
expectation and anticipation, that are at the basis of the placebo effect. Moreover, 
the dlPFC also has connections with motor brain areas, thus suggesting a potential 
role of this brain region in the motor placebo effect. Part of my Ph.D. project was 
dedicated to tackle the role of the dlPFC in the motor placebo effect in healthy 
participants. In Part II of this thesis, I will describe a series of three experiments in 
which we applied non-invasive brain stimulation combined with a placebo 
procedure on force production. This investigation has allowed to enlarge the current 
knowledge on the neural correlates of the placebo effect in the motor domain, by 
demonstrating that the dlPFC could also play a role, especially when expectation is 
the main cognitive mechanism at the basis of the placebo effect. 
With regard to the second issue, so far, the behavioral investigation of the placebo 
effect has addressed some dimensions of motor performance, such as force 
production, movement speed and resistance to fatigue (Beedie & Foad, 2009; Fiorio 
et al., 2018; Pollo et al., 2011). The potential effects of placebo on other crucial 
motor functions remains unknown. Motor performance is a complex definition that 
embraces different dimensions, such as precision control, balance, visuomotor 
coordination, motor sequence learning and motor adaptation, among others. Some 
of these motor functions are important not only in sports, but also in daily life 
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activities. Hence, extending the behavioral investigation of the placebo effect on 
other motor functions may help to achieve a better understanding of the placebo 
effect itself, as well as to enlarge its range of application to daily life activities. 
During my Ph.D., I have tried to explore whether a placebo procedure can improve 
two relevant motor functions present in our daily life, like balance control and motor 
sequence learning. Balance can be defined as the capacity “to control the body’s 
position in space for stability and orientation” (O’Sullivan, 2007). Balance control 
is crucial to accurately perform most of the activities in daily life, such as getting 
up from bed, walking, waiting on a queue or simply having a shower. Conversely, 
disturbances in balance control, such as those present in Parkinson’s disease or in 
the elderly population can lead to higher risk of fall, which limits the quality of life 
(Jacobs et al., 2005; Maki et al., 1994; Pfortmueller et al., 2014). In Part III of this 
thesis, I will describe a new protocol that we developed to improve balance control 
in healthy participants with a placebo procedure. We think that extending the 
potential beneficial effects of placebos on balance control may allow to provide in 
the future new strategies for the rehabilitation of gait disorders for which the 
pharmacological treatment is often not effective.  
Motor skill learning in another important motor function that permits to convert 
isolated and specific movements into well-performed skills through practice (Dayan 
& Cohen, 2011; Wolpert et al., 2011). In particular, motor sequence learning is 
crucial in many tasks, such as cooking and cleaning, and to acquire skills, like 
writing or cycling that are present during the lifespan. In Part III of this thesis, I 
will describe a study that we conducted to investigate the placebo effect on the 
learning of motor sequences in healthy participants. Even in this type of study, we 
envisage a potential future impact for rehabilitative trainings after an injury (i.e. 
stroke) (Kitago & Krakauer, 2013).  
To summarize, with this work we have tried to expand the current knowledge on 
the placebo effect in the motor domain from two different perspectives: from one 
hand, we have conducted a neural investigation on the involvement of a higher-
order brain region (the dlPFC) in the motor placebo effect; from the other hand, we 
have enlarged the behavioral investigation of the placebo effect to two different 




The placebo effect is a fascinating psychobiological phenomenon that allows to 
investigate the mind-body interaction. It is typically induced by the application of 
an inert treatment along with verbal suggestion of beneficial outcomes. The placebo 
effect has been deeply investigated in the field of pain, although different lines of 
evidence suggest that it is also present in other domains, like the motor domain. 
Extending our knowledge of the placebo effect in the motor domain can have 
important future translational impacts in sports and pathology. The aim of my PhD 
project was to study the placebo effect in the motor domain at two different levels: 
the neural and the behavioral level.  
Regarding the neural level, knowledge on the brain regions related to placebo effect 
in the motor domain is limited. We aimed at filling in this knowledge gap by 
investigating the role of the dlPFC, a brain region also involved in placebo 
analgesia. The dlPFC elaborates expectation, a cognitive function at the basis of the 
placebo effect and shares some connections with other brain regions involved in 
motor control. Hence, there are many clues to hypothesize a role of the dlPFC in 
the motor placebo effect. To tackle this issue, three different experiments were 
conducted in which the dlPFC was stimulated by means of transcranial direct 
current stimulation (tDCS) together with a placebo procedure on force production. 
We found that the left dlPFC is involved in the expectation-induced enhancement 
of force, specifically in those subjects who respond to the placebo effect (placebo-
responders). 
Regarding the behavioral level, it should be noticed that many behavioral studies 
have shown that the placebo effect can enhance different aspects of motor 
performance associated to sports, such as force, speed or endurance. It is still 
unknown, however, whether the placebo effect can also improve other motor 
functions, important for many daily life activities, like balance or motor sequence 
learning. Thus, another objective of my PhD was to investigate the potential 
influence of the placebo effect on two motor functions that are closer to daily life 
activities. To this aim, a first study was conducted to understand whether balance 
control, a motor function needed for many daily life activities and for preventing 
falls, could be enhanced in healthy participants by a placebo procedure consisting 
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of verbal suggestion. We found that different parameters of balance (in the three-
dimensional space and in the medial-lateral direction) and the subjective perception 
of stability were improved by the placebo procedure. 
A second behavioural study was run to investigate whether the application of a 
placebo treatment consisting of verbal suggestion could help in improving motor 
sequence learning. In this case, we also aimed to tackle a differential role of two 
types of placebo treatments: one motor and one cognitive. The motor placebo 
procedure consisted of transcutaneous electrical nerve stimulation (TENS) applied 
the hand muscles involved in the task together with verbal information on the 
beneficial effects on muscle activity. The cognitive placebo procedure consisted of 
sham transcranial direct current stimulation (tDCS) applied over the frontal region 
together with verbal information on the beneficial effects on attention. Our findings 
did not show a clear improvement of performance following the placebo 
procedures, but a significant effect on the subjective perception of fatigue. More 
precisely, while the placebo procedure directed to the motor function (TENS) could 
reduce the perception of physical fatigue, the placebo procedure focused on 
cognitive functions (sham tDCS) could decrease the perception of both mental and 
physical fatigue. 
Altogether these investigations represent an attempt to deepen our understanding of 
the neural correlates of the motor placebo effect and to enlarge the potential 
behavioural influence of placebos on different motor functions.  
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PART I: BACKGROUND  
 
Definition of the placebo effect 
Placebo is a latin word that means “I shall please” and it was first documented in 
the Vespers for the Dead (Psalm 116, 9th verse) as Placebo Domino in regione 
vivorum (Hart, 1999; Jacobs, 2000). By that time, the term placebo started to be 
used with the notion of “pleasing”. For example, some mourners were hired to “sing 
placebos” to adulate the dead at the burials (Kerr et al., 2008). 
Some years had to elapse to find the word placebo associated to the medical lexicon. 
During the late 18th century, a British physician used the word placebo for 
describing a method to give comfort and please to patients with illnesses without 
cure (Kerr et al., 2008), thus associating the word to console or relieve more than 
to cure. Several years later, in 1811, a new explanation of the word placebo was 
registered and defined in the Hooper’s Medical Dictionary. Placebo was defined as 
“any medicine adapted more to please than benefit the patient” (Kerr et al., 2008; 
Finniss, 2018).  
During the 20th century, the term placebo started to be slightly transformed and 
associated to therapeutic rituals and deception (Carlill, 1918). But it was during the 
mid-20th century when the word placebo started to be associated with the placebo 
effect. In 1955, Henry K. Beecher discovered the effect of placebo by using a 
placebo-controlled double-blinded design, using the placebo as a tool to dissociate 
the real pharmacological effect from the suggestion that arises when a 
pharmacological treatment is applied. In his article, the placebo resulted effective 
in the 35.2% of the cases and the effect was associated to the subjective component 
that emerges from the applied treatment. Several subsequent researches have 
attempted to obtain a better definition of the placebo effect (Benedetti, 2002; 
Shapiro, 1997; Vase, 2002).  
A related aspect to consider is the difference between the terms placebo effect and 
placebo response that are usually considered interchangeable in the literature, 
although a difference exists between these two terms. According to Hoffman et al. 
(2005), the term placebo response refers to the individual change that is caused by 
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a placebo manipulation or treatment simulation, while the term placebo effect refers 
to the average enhancement that occurs in a group of subjects after receiving a 
placebo manipulation or treatment simulation. 
Today, the most accepted definition of the placebo effect refers to a 
psychobiological phenomenon that could be defined as a physical or psychological 
benefit following the administration of an inert substance (or sham treatment) 
together with a positive context inducing positive expectations about its effect 
(Benedetti et al., 2016).  
 
Cognitive mechanisms of the placebo effect 
Placebo responses are the result of a complex interaction of different 
biopsychosocial factors, such as cognitive functions like expectation and learning, 
personality traits and genetic factors (Colagiuri et al., 2015; Colloca et al., 2014; 
Colloca & Miller, 2011; Corsi & Colloca, 2017; Peciña et al., 2013). In particular, 
expectation and learning represent the main cognitive mechanisms implicated in 
the modulation and formation of the placebo effect. 
The expectancy model is considered as the central mechanism for the development 
of the placebo effect and makes a special mention of the importance role of verbal 
suggestions (Colloca & Miller, 2011; Kirsch, 2018). According to the Theory of 
Expectancy (Kirsch, 1985), the previous belief of a person about what will happen 
in certain circumstances will determine what that person will experience in the end. 
Thus, a response (placebo) can occur as consequence of expecting a positive 
outcome. In other words, the expectation can be generated by positive verbal 
suggestions associated with a treatment (actually inert), thus inducing a positive 
expectation and creating a real effect. This induction of positive expectation about 
the effect of an ergogenic aid (actually inert) in reducing symptoms (i.e., pain) can 
be sufficient to modify pain perception, pain sensation and dopamine release 
(Benedetti et al., 2003) and can also modulate motor and cognitive performance 
(Beedie et al., 2009; Colagiuri et al., 2011). 
Another crucial psychological mechanism to induce the placebo effect is learning. 
It has been demonstrated that different types of conditioning, such as classical 
conditioning or instrumental conditioning, are responsible for the formation of the 
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placebo effect (Benedetti et al., 2003; Colloca & Miller, 2011; de la Fuente-
Fernández et al., 2009). Classical conditioning in the placebo field, has been 
proposed as the primary method to produce learning (Colloca et al., 2010; 
Montgomery & Kirsch, 1997; Voudouris et al., 1990). In this case, a previous 
experience of benefit associated with the exposure of a real treatment effect can 
later turn out to be beneficial when the real treatment is replaced by an inert 
(similar) treatment. The length of the learning process is a determinant factor for 
the placebo effect, in that a longer learning period during the placebo manipulation 
or treatment simulation resulted in stronger placebo response (Colloca et al., 2010). 
Interestingly, another type of learning, such as social observation, can produce 
placebo effects (Colloca & Benedetti, 2009; Schenk et al., 2017). Specifically, a 
person could learn how to respond to a condition by just observing the beneficial 
effect of a demonstrator after the application of a treatment. 
These two-main cognitive mechanisms, expectation and learning, can interact to 
generate and maintain placebo effects (Ashar et al., 2017). In agreement with a 
cognitive interpretation of conditioning (Reiss, 1980; Rescorla, 1988), reinforced 
expectations can be induced after a conditioning procedure. In this way, after 
repeated exposure to the effects of a treatment, the individual knows what to expect 
when the treatment is applied again (Kirsch, 2018). Evidences converge in 
indicating that the placebo effect induced by the combination of both verbally-
induced expectancy and conditioning results in stronger effects (Colloca et al. 2008; 
Schafer et al. 2015) than the placebo effect induced by the application of only verbal 
suggestion (Colloca et al., 2008; de Jong et al., 1996) or only conditioning 
(Montgomery & Kirsch 1997). Up to now, these evidences support the idea that 
recurrent positive experiences along with a cognitive ascription of benefit to the 
treatment is the best combination to obtain strong placebo effect (Ashar et al., 
2017). 
 
Neural correlates of placebo analgesia 
Many studies have investigated the neural underpinnings of the placebo effect in 
pain. As we know, different cognitive mechanisms can induce a placebo response. 
Thus, the placebo effect cannot be supported by a simple brain mechanism or 
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system (Ashar et al., 2017). In Benedetti’s words, “there is not a single placebo 
effect but many” (Benedetti, 2006). Therefore, different neural mechanisms could 
be also engaged depending on the function on which the placebo effect works (for 
instance, pain). Understanding the numerous neurobiological mechanisms that are 
involved in different placebo responses can help to understand the complex mind-
brain-body interaction (Benedetti, 2006). 
A considerable number of researches have explored the neural correlates of the 
placebo effect with different modern techniques such as electroencephalography 
(EEG), magnetoencephalography (MEG), functional magnetic resonance imaging 
(fMRI) or positron emission tomography (PET). It is important to note that most of 
the studies have focused on placebo analgesia (Ashar et al., 2017; Wager & Atlas, 
2015). There is clear evidence that placebo procedures can significantly reduce 
pain-related responses occurring in the pain-processing system (Wager & Atlas, 
2015). A clear and direct correlation was demonstrated between high placebo 
responses and reduced activity in pain-processing systems (Wager et al. 2007) or 
brain areas such as the dorsal anterior cingulate cortex, the thalamus and the mid- 
and anterior insula among others (Geuter et al., 2013; Wager & Atlas, 2015; Watson 
et al., 2009). For example, the responses related to pain that occur in the 
somatosensory areas and in the behavior are due to the network that connects the 
anterior cingulate cortex and the periaqueductal grey (Lui et al., 2010; Wager et al., 
2004). Interestingly, the placebo effect is not related only with the central 
components of pain. Brain regions involved in higher-order cognitive functions, 
like anticipation of benefit and expectation play also a role in the placebo effect. 
Some of these brain areas show activation before and during painful stimulation, 
like the dlPFC, the ventromedial prefrontal cortex or the mid-lateral orbitofrontal 
cortex (Kong et al., 2006; Wager & Atlas, 2015; Watson et al., 2009). Moreover, 
the increased activity of the reported brain areas directly correlates with the amount 








Figure 1. Neural correlates of placebo analgesia. A general view of some brain areas 
involved in the placebo analgesic effect. The areas that are represented in orange are 
involved in pain perception and show reduced activation after a placebo treatment. Some 
of these areas are the thalamus (Thal), periaqueductal grey (PAG), dorsal anterior cingulate 
cortex (dACC) and secondary somatosensory (S2) among others. Moreover, the areas that 
are represented in green are also related to other higher-order functions, like expectation or 
maintenance of context information. These areas show increased activation before or 
during a placebo treatment. These areas include the dorsolateral prefrontal cortex (dlPFC), 
the ventromedial prefrontal cortex (vmPFC), the lateral orbitofrontal cortex (lOFC) and 
periaqueductal grey (PAG) among others. Adapted from Wager & Atlas, 2015. 
 
The placebo effect can also modify the release of different neurotransmitters. It has 
been discovered that the administration of naloxone, an opioid antagonist, could 
block the effect of placebo, thus demonstrating the involvement of the endogenous 
opioid system in placebo analgesia (Levine et al., 1978). From this first experiment, 
several studies have characterized the placebo effect in pain using naloxone, like 
reduction of heart rate or decrease β-adrenergic response (Colloca & Benedetti, 
2005: Pollo et al., 2003).  
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The placebo effect in the motor domain 
The investigation of the placebo effect in the motor domain is not new, going back 
to the 70’s when Ariel and Saville (1972) performed a study on weightlifters and 
noticed that athletes who thought to have taken an ergogenic aid (actually a placebo) 
improved the performance. Since then, many other behavioral studies demonstrated 
the powerful effect of placebo in many sports (Beedie & Foad, 2009; Pollo et al., 
2011). More recently, the investigation was enlarged to experimental models of 
motor performance in laboratory settings both in athletes and non-athletes 
(Benedetti et al., 2007; Carlino et al., 2014; Kalasountas et al., 2007; McKay et al., 
2012). Finally, the interest on this field has become always wider to include also 
the neurophysiological investigation on the neural bases of the effect.  
I will describe in more detail some of these studies in the following parts of my 
thesis, since my main interest was to study different levels of the placebo effect in 
the motor domain.   
 
General aims 
All the studies on placebo analgesia were very important in starting the 
experimental investigation on the neural and cognitive mechanisms of the placebo 
effect. As anticipated in the Preface, my interest was to export this investigation to 
the motor domain. In this regard, some questions still remain unanswered and 
during my Ph.D., I tried to design some studies to answer at least in part some of 
these questions. In particular, one goal of my research was to understand the role of 
a frontal brain area (like the dlPFC) in the placebo effect in the motor domain (Part 
II). Furthermore, I tried to enlarge the investigation of the behavioral aspects of the 
motor placebo effect by tackling two motor functions that are crucial in daily life 
activities (and not only in sports, as mainly investigated so far), like balance control 





PART II: NEURAL INVESTIGATION OF THE PLACEBO EFFECT IN 
THE MOTOR DOMAIN 
 
Current knowledge on the neural correlates of the motor placebo effect 
The neural correlates of the placebo effect in the motor domain are still largely 
unknown. So far, only two studies in healthy subjects have shown the contribution 
of some cortical brain areas in the placebo effect in the motor domain (Fiorio et al., 
2014; Piedimonte et al., 2015). Fiorio et al. (2014) investigated whether the primary 
motor cortex (M1) could contribute to the behavioral increase of force production 
after a placebo procedure. To this end, the Authors used single-pulse transcranial 
magnetic stimulation (TMS) over M1 to evaluate the excitability of the 
corticospinal system. Motor evoked potentials (MEP) and cortical silent period 
(CSP) could be recorded with surface electrodes positioned over the muscle 
involved in the force task (i.e., the first dorsal interosseous). The amplitude of the 
MEP served as indirect measure of cortical and spinal motor circuits activity 
(Rösler & Magistris, 2008) and the duration of the CSP represented activity of 
inhibitory circuits at the cortical level (Wolters et al., 2008). Healthy subjects were 
randomized in four different groups: only verbal suggestion (I); verbal suggestion 
and conditioning (II); control with inert treatment (III) and control without inert 
treatment (IV). Participants were required to perform a motor task consisting of an 
abduction movement of the right index finger against a piston. They were instructed 
to press as strongly as possible and could see in real-time a visual feedback of the 
exerted force. Subjects of group I and II (experimental groups) underwent a placebo 
procedure consisting in the application of an inert electrical device (transcutaneous 
electrical nerve stimulation, TENS) over the muscle involved in the task together 
with positive verbal suggestion of improvement. Additionally, participants of group 
II received a conditioning procedure consisting of a surreptitious increase of the 
visual feedback of force. Groups III and IV served as control; with the former 
receiving the same TENS application but with overt verbal information that it was 
inert and the latter performing the same motor task but without TENS application. 
To explore the involvement of M1 in the placebo effect, single-pulse TMS was 
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delivered when all the participants exerted the same amount of force (i.e., 30% of 
the maximum voluntary force). Results showed higher MEP amplitudes after the 
placebo procedure in both experimental groups (I and II). Furthermore, the duration 
of the CSP was reduced only in the group who received verbal suggestion and 
conditioning (II). These findings suggest that the excitability of the corticospinal 
system can be modulated by a placebo procedure and results in higher force 
production.  
The second evidence on the neural correlates of the motor placebo effect in healthy 
participants derives from an EEG study by Piedimonte et al. (2015). The study 
investigated the effect of a placebo procedure in reducing fatigue in a strength task. 
A specific component, called readiness potential (RP), was extracted from the EEG 
signal. The RP is associated to the preparation of voluntary movements (Shibasaki 
& Hallett, 2006) and is modulated by fatigue (Schillings et al., 2006; Slobounov et 
al., 2004). Moreover, the supplementary motor area (SMA) and M1 have been 
proposed as brain sources of the RP (Deecke, 1996; Shibasaki & Hallett, 2006). 
The task consisted of a repetition of flexion movements for lifting a weight with the 
index finger to induce fatigue. Participants were divided in two groups, placebo and 
control. The placebo group had to ingest a substance (actually inert) along with 
verbal suggestion that it was caffeine and could reduce fatigue. The control group, 
instead, did not received any treatment. Results showed that while in the control 
group there was higher perception of fatigue and higher RP amplitude after the 
procedure, in the placebo group perception of fatigue was reduced and the RP 
amplitude did not increase through the experiment. According to the Authors, a 
central mechanism could play a role in the placebo-induced decrease of fatigue, 
before movement execution (Piedimonte et al., 2015). 
A different approach to investigate the neural correlates of the placebo effect in the 
motor domain derives from patients with motor symptoms, like Parkinson’s 
disease. Parkinson’s disease is a neurodegenerative disorder of the basal ganglia. A 
reduction of dopaminergic neurons in the substantia nigra is the cause of the 
occurrence of motor symptoms (Opara et al., 2017). A direct and straightforward 
comparison of the neural correlates of the motor placebo effect of parkinsonian 
patients with healthy individuals may be risky and a matter of bias. Nonetheless, 
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the results obtained from studies in parkinsonian patients can give important 
information on the neural correlates of the motor placebo effect. Parkinson’s 
disease allows to explore how subcortical structures, like the basal ganglia, are 
related to cognitive and motor functions (Mallet et al., 2007).   
Different studies have demonstrated that the dopaminergic system can be 
modulated by a placebo procedure. Specifically, de la Fuentes-Fernández et al. 
(2001 and 2002) made a positron emission tomography study to evaluate the 
amount of raclopride, an antagonist of dopamine receptors, after a placebo 
procedure in parkinsonian patients. The Authors found a reduced amount of 
raclopride in both the dorsal and the ventral striatum after placebo administration, 
suggesting that the placebo effect could be associated to the release of endogenous 
dopamine in subcortical structures (de la Fuentes-Fernández et al., 2001; de la 
Fuentes-Fernández et al., 2002). In another study (Lidstone et al., 2010), the amount 
of dopamine release in the striatum was modified depending on the told probability 
to receive an active treatment (actually a placebo). Precisely, patients who though 
to had 75% or 100% probabilities of receiving the treatment showed a significant 
increase of dopamine release, while those who though to had 25% or 50% of 
receiving the treatment did not show any change. The study demonstrated that the 
dopamine release in the striatum is related to the expectation of benefit subsequent 
to a placebo treatment (Lidstone et al., 2010). 
The surgery to implant deep brain stimulation (DBS) in parkinsonian patients 
allows to evaluate the activity of neurons of the stimulated area. 
Electrophysiological studies showed the involvement of the subthalamic nucleus 
(STN) in the placebo effect. Benedetti et al. (2004) investigated the firing rate of 
the neurons of the STN after a placebo procedure in selected patients who were 
waiting for neurosurgical intervention with DBS. Once selected, patients underwent 
a conditioning procedure consisting of the administration of apomorphine 
(dopamine agonist) before the surgical intervention. During the surgery, injection 
of saline solution along with verbal suggestion of motor improvement was applied 
to the patients. The placebo procedure was applied during the electrophysiological 
recording of the neural activity in the STN. Benedetti et al. (2004) demonstrated 
that after a placebo procedure, some patients (responders) showed a reduction of 
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muscular rigidity and also a reduced discharge frequency and evoked non-bursting 
activity in the STN.  
To deeper understand the potential changes of other subcortical structures in the 
motor placebo effect, Benedetti et al. (2009) recorded the activity of the substantia 
nigra pars reticulata (SNr), the ventral anterior (VA) and the anterior ventrolateral 
(VLa) nuclei of the thalamus. All these structures are involved in motor control and 
connected to the STN. Using a similar paradigm, they found a significantly lower 
activity in the STN and the SNr, whereas neuronal activity was higher in the VA 
and VLa nuclei only in patients who showed a reduced muscle rigidity. Moreover, 
a recent study demonstrated that to obtain clinical and neural changes (in the 
thalamus) a conditioning procedure should be used in which a real drug is 
administered together with the placebo procedure (Benedetti et al., 2016). 
As we have been observing above, different cortical and subcortical structures (M1, 
SMA, STN, SNr, VA and VLa) are involved in the placebo effect in the motor 
domain and, interestingly, these structures are connected with other brain areas, 
such as the dlPFC (Hasan et al., 2013; Mayberg et al., 2002; Miller & Cohen, 2001), 
the cingulate cortex (Asemi et al., 2015; Mayberg et al., 2002; Petrovic et al., 2002), 
or the orbitofrontal cortex (Petrovic et al., 2002) which in turn have also been 
related to placebo analgesia (Ashar et al., 2017; Wager & Atlas, 2015). Hence, these 
evidences emphasize the idea that some of these areas could also have a role in the 
motor placebo effect. Among all these brain regions, the dlPFC seem to be a suitable 
candidate, due to it has a relevant role in placebo analgesia and in higher-order 
cognitive functions, like expectation and anticipation, which are considered the 
basis of the placebo effect. Remarkably, it has been demonstrated that it 
communicates with motor brain areas, thus indicating a potential role in the motor 
placebo effect.   
In particular, this second part of my thesis describes a series of three experiments 
conducted to investigate the involvement of the dlPFC in the motor placebo effect. 
To this purpose, we proposed a motor task to measure the subjects’ force level 
before and after a placebo procedure and modulated the activity of the dlPFC by 
means of non-invasive brain stimulation with transcranial direct current stimulation 
(tDCS). The selection of a force task among all the other motor task (i.e. movement 
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speed or resistance to fatigue) was due to one main reason. That is, a previous study 
has demonstrated the paradigm on the neural correlates of force during a placebo 
procedure (Fiorio et al., 2014). Thus, supporting by this study, we could investigate 
whether other brain areas involve in force (in our case the dlPFC) could also be 
modulated by a placebo procedure.  
 
On the role of the dorsolateral prefrontal cortex 
So far, a very limited number of studies attempted to investigate the potential neural 
correlates of the placebo effect in the motor domain. As mentioned previously, only 
two studies tackled this issue in healthy participants. More precisely, a first study 
has shown that the placebo-induced enhancement of force was related to an increase 
of activity in the left M1 (Fiorio et al., 2014). This was possible thanks to the 
application of TMS in healthy participants, which allowed to observe an enhanced 
amplitude of the motor evoked potentials and a shortening of the cortical silent 
period after the placebo procedure (Fiorio et al., 2014). A following EEG study 
showed that the placebo-induced decrease of fatigue was associated to a stable 
amplitude of the readiness potential (Piedimonte et al., 2015). The readiness 
potential is interpreted as the anticipatory phase of a movement and arises from the 
supplementary motor area and M1 (Deecke, 1996; Shibasaki & Hallett, 2006). 
Hence, the two studies in healthy participants indicate that two cortical areas (M1 
and SMA), involved in movement execution and preparation play a role in the 
motor placebo effect.  
Nonetheless, a more complex brain network is necessary for the cognitive control 
of motor behavior. The dlPFC together with other frontal regions, plays a prominent 
role in this complex network (Hasan et al., 2013; Miller & Cohen, 2001). It is worth 
mentioning that several studies have demonstrated that the dlPFC has an important 
role in placebo analgesia (Egorova et al., 2015; Geuter et al., 2013; Kong et al., 
2006; Krummenacher et al., 2010; Lui et al., 2010; Peciña et al., 2013; Wager et al., 
2004; Watson et al., 2009) and in elaborating expectation. As we know from the 
literature, expectation is one of the crucial cognitive mechanisms at the basis of the 
placebo effect (Krummenacher et al., 2010; Jubb & Bensing, 2013). Consequently, 
it is rational to conjecture that the dlPFC could be a potential actor in the placebo 
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modulation of motor performance. Our goal was to explore this hypothesis. To this 
end, we decided to apply the tDCS over the dlPFC during a placebo procedure in 
the motor domain, and precisely on a force task. The control of force requires the 
activation of both cortical and subcortical brain regions, like the prefrontal cortices, 
the cingulate motor area, premotor area, pre-SMA, SMA, the cerebellum and the 
basal ganglia, as we know from neuroimaging studies (Badoud et al., 2017; 
Dettmers et al., 1995; Ehrsson et al., 2000; Neely et al., 2013; Schmitz et al., 2005; 
Vaillancourt et al., 2007; Wasson et al., 2010). Several of these brain areas are 
connected with the dlPFC and they could exert a potential top-down control on 
force through the activity of the dlPFC (Alexander et al., 1986; Bates & Goldman-
Rakic, 1993; Cieslik et al., 2013; Lu et al.,1994; Miller & Cohen, 2001; 
Schmahmann & Pandya, 1997; Petrides & Pandya, 1999). Additionally, the dlPFC 
is also involved in the selection of the quantity of force to be applied (Vaillancourt 
et al., 2007) and in the prediction of force amplitude (Wasson et al., 2010), 
supporting a direct role of the dlPFC in the cognitive control of force. As far as we 
know, no study so far has tackled the role of the dlPFC in the placebo effect on 
force. 
Although there is clear evidence on the role of the dlPFC on placebo analgesia, 
there is not a definite role on the hemisphere (whether the left or the right dlPFC). 
Some studies reported that the left dlPFC is involved in placebo analgesia (Peciña 
et al., 2013; Watson et al., 2009), whilst other studies suggested the involvement of 
the right dlPFC (Egorova et al., 2015; Lui et al., 2010). Finally, other studies have 
demonstrated that the left and right dlPFC could act bilaterally in placebo analgesia 
(Kong et al., 2006; Krummenacher et al., 2010; Wager et al., 2004). It could be 
speculated that the type of experimental protocol and procedure adopted could 
partly explain the different results (Egorova et al., 2015; Lui et al., 2010). In our 
study, subjects had to perform the motor task with the right hand, requiring the 
involvement of the contralateral (left) primary motor cortex. Hence, in our study 
we hypothesized that the left dlPFC could be involved in the placebo-induced 
enhancement of force. The role of the left dlPFC was evaluated in three separate 
experiments and we implemented a within-subjects design in which anodal, 
cathodal and sham tDCS was applied to the same participant in three different days.  
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Transcranial direct current stimulation (tDCS) 
We decided to apply non-invasive brain stimulation, in particular the tDCS, during 
a placebo procedure to investigate the left dlPFC. It may be worth describing the 
basic principles of tDCS before continuing with the study description. This little 
introduction about the tDCS helps to better clarify the reasoning behind the 
application of this technique together with a placebo procedure in the motor 
domain. 
Non-invasive brain stimulation (NIBS) techniques, like repetitive transcranial 
magnetic stimulation (rTMS) and transcranial electrical stimulation (tES) are 
widely used as a research tool for studying the human motor and cognitive functions 
(Brunoni et al., 2012; Jacobson et al., 2012; Pascual-Leone et al., 1994; Perceval et 
al., 2016; Wassermann et al., 1998). Specifically, tES allows to modulate the state 
of the cerebral cortex by applying a very low electrical current over the scalp. 
Among all the existing types of tES, transcranial direct current stimulation (tDCS) 
has become the most widely known, investigated and used technique to investigate 
cognitive processes (Antal et al., 2014; Bestmann et al., 2015; Santarnecchi et al., 
2015). 
Back to the 60s, Bindman et al. (1964) demonstrated that the stimulation of the rat’s 
cortex with subthreshold direct current induced a change of the cortical activity in 
a polarity-dependent manner (Bindman et al.,1964). Thirty years later, this effect 
was proven also in the human brain (Nitsche & Paulus, 2000; Priori et al., 1998). 
TDCS consists of a low-intensity direct current (1 to 2 mA) applied over the scalp 
by means of a pair of rubber electrodes (typically 25 or 35 cm2) inserted in sponges 
that are soaked in saline solution (Stagg & Nitsche, 2011). TDCS can induce neural 
changes in the cortical activity, functional connectivity and metabolite 
concentrations and in this way, it can modulate human behavior (for a review, 
Fertonani & Miniussi, 2017; Nitsche et al., 2015). Thus, tDCS can temporarily 
interfere with the activity of a cortical network and in the meantime, it is possible 
to test the effects of this interface on specific tasks. Different motor and cognitive 
functions have been shown to be modulated by the application of tDCS on specific 
brain regions (for a review, Perceval et al., 2016; Shin et al., 2015).  
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Regarding the type of stimulation, tDCS can be applied in two active ways, anodal 
and cathodal stimulation. Concerning anodal stimulation, the anode (positive 
electrode) is placed over the target brain area under investigation whereas the 
cathode (negative electrode) is positioned over a reference area. With regards to 
cathodal stimulation, the electrode position is reversed, so that the cathode is placed 
over the target brain area of interest and the anode over the reference one. 
Furthermore, tDCS allows the application of an inactive condition, the so-called 
sham stimulation, which can emulate similar sensations on the skin like the active 
condition, but without any cortical modulation (Gandiga et al., 2006; Nitsche et al., 
2008). Most of the studies indicate that anodal stimulation increases cortical 
excitability while cathodal reduces it. However, with regards to the cognitive 
domain, the inference anodal equals improved performance and cathodal equals 
impaired performance is not always possible. Namely, factors like the intensity of 
stimulation, the duration of stimulation or the cortical activation state at the time of 
the stimulation can produce different unexpected outcomes (Batsikadze et al., 2013; 
Monte-Silva et al., 2013; Silvanto et al., 2008). Thus, it is important to consider 
tDCS not only as a tool that can increase or decrease cortical excitability of a brain 
area but also a tool that can alter the signal to noise ratio in the stimulated area 
(Santarnecchi et al., 2015). Furthermore, authors like Bestmann et al. (2015) or 
Fertonani & Miniussi (2017) have aid to better understand the potential effects of 
tDCS considering different mechanisms inner to the method of stimulation. 
The application of tDCS in the cognitive domain has allowed to investigate 
different goals, like the enhancement of cognitive functions, the investigation of the 
role of specific cortical areas involved in a specific function, and the investigation 
of the neurophysiological mechanisms related to a specific cognitive function 
(Parkin et al., 2015). Many studies have demonstrated the modulation of a 
considerable amount of cognitive functions with tDCS, like working memory 
(Schicktanz et al., 2015), strategic planning ability (Kaller et al., 2013), attention 
(Pecchinenda et al., 2015), semantic processing (Brückner & Kammer, 2017) or 
motor learning (Hardwick & Celnik, 2014). One of the crucial point of tDCS is the 
possibility to be applied together with motor or cognitive tasks, allowing thus to 
modulate a specific region not only before or after the performance of a task (offline 
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stimulation) but also during the performance of the task (online stimulation) (Thair 
et al., 2017) 
Other features like being easily portable, having a low price and being easy to apply 
have made tDCS a widely used technique (Antal et al., 2014; Parkin et al., 2015; 
Sathappan et al., 2018). Furthermore, another advantage of tDCS is the very few 
side-effects that it evokes. An electrical stimulation with a current density between 
0.028 to 0.08 mA/cm2, usually induces a mild tingling or light itching sensation on 
the scalp during the stimulation, redness of the skin or more rarely, burning 
sensations (Nitsche et al., 2008; Poreisz et al., 2007). Thanks to this, tDCS produces 
very low side-effects compared to other NIBS techniques, like TMS.  Last but not 
least, tDCS has a reliable sham condition that allows subjects to perceive the same 
sensation as during the active stimulation, without changing the cortical excitability 
(Gandiga et al., 2006; Nitsche et al., 2008). Taking altogether, tDCS can be 
considered as a potential tool to investigate the neural mechanisms of different 
cognitive and motor functions (Shin et al., 2015). Thus, tDCS is presented as a 
suitable method to investigate the selected brain area, like the dlPFC, during a 
placebo procedure in the motor domain.  
Thus, as above mentioned, the role of the left dlPFC was evaluated in three separate 
experiments. We applied a within-subjects design in which anodal, cathodal and 
sham tDCS was applied to the same participant in three different days. In particular, 
in Experiment 1 (expectation alone) expectation was the main cognitive mechanism 
involved because the placebo procedure consisted of verbal suggestion alone. 
Instead, in Experiment 2 (expectation and conditioning) both expectation and 
learning were induced by the placebo procedure consisting of verbal suggestion and 
conditioning. Finally, in Experiment 3 (control procedure) the same force task was 
performed without any verbal suggestion and conditioning. This experiment 
allowed to rule out any effect of tDCS per se on motor performance. According to 
the general idea of tDCS in which anodal tDCS tends to induce excitability in the 
stimulated brain region, while cathodal tDCS induces inhibition (Filmer et al., 
2014; Miniussi et al., 2013; Wagner et al., 2007), we anticipated that anodal and 
cathodal tDCS over the dlPFC should interfere with the motor placebo effect, by 
enhancing it or reducing it, respectively. On the other hand, sham tDCS is typically 
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applied as control stimulation and therefore it should not interfere with the placebo 
effect. Furthermore, we predicted that the effects of tDCS should arise especially in 
Experiment 1, in which expectation is the key mechanism attributable to the role of 
the dlPFC in expectation. Lastly, we anticipated that these effects could be more 




Three different experiments were carried out. The sample size was computed for 
each experiment using G-Power 3.1 (Faul et al., 2007), in which we considered F 
tests within factors with one group and six measurements (two sessions and three 
tDCS stimulations). We derived the effect size from a previous study that used the 
same motor placebo paradigm in different groups of healthy participants (Fiorio et 
al., 2014). For Experiment 1 (expectation alone), we used the information from the 
study of Fiorio et al., (2014). Precisely, in the group with expectation alone, the 
partial eta squared for the significant effect of Session (baseline vs. final) for the 
percentage of strong pressure (Strongpress), that represents force, was 0.111 
equivalent to an effect size of 0.353. Regarding the obtained effect size (0.353), 
Power (1-β error probability) of 0.95, α error probability of 0.05, 6 measurements 
and correlation among repeated measures of 0, the resulting sample size is 28. 
Therefore, we made the decision to recruit more subjects to avoid dropping out of 
participants and to allow for a more robust counterbalancing of the stimulation 
sessions. Hence, 32 healthy volunteers were recruited (14 females; mean age: 21.4 
± 2.7). They were all right-handed expect one ambidextrous. In order to recruit 
participants with regards to Experiment 2 (expectation and conditioning), we based 
our sample size computation on a similar group from Fiorio et al. (2014) in which 
they received verbal suggestion and conditioning. The partial eta squared for the 
same interaction was 0.415, which correspond to an effect size of 0.842. Once 
again, by considering this effect size, α error probability of 0.05, Power (1-β error 
probability) of 0.95, 6 measurements and correlation among repeated measures of 
0, the resulting sample size is 6. However, we made the decision to recruit more 
subjects to prevent drop-outs and to allow for a more robust counterbalancing of 
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the stimulation sessions. In this experiment, therefore, 19 healthy volunteers were 
recruited (8 females; mean age: 21.6 ± 2.9). They were all right-handed expect one 
left-handed. For the control group (Fiorio et al., 2014) the partial eta squared for the 
same interaction, described above, was 0.311, corresponding to an effect size of 
0.671. Regarding the obtained effect size (0.671), α error probability of 0.05, Power 
(1-β error probability) of 0.95, 6 measurements and correlation among repeated 
measures of 0, the resulting sample size is 9. Thus, to prevent drop-outs and to allow 
for a more robust counterbalancing of the stimulation sessions 14 healthy volunteers 
were recruited (6 females; mean age: 23.5 ± 2.5). They were all right-handed expect 
one left-handed. 
None of the participants presented neurological or psychiatric disease or 
contraindication to tDCS (Nitsche et al., 2008). Participants were free of medication 
(except contraceptives) at the time of the experiment. Moreover, participants were 
instructed to avoid consumption of alcohol and caffeinated drinks prior to the 
experiment. The protocol was approved by the local ethical committee of the 
Department of Neurosciences, Biomedicine and Movement Sciences of the 
University of Verona. Participants gave written informed consent in accordance 
with the Declaration of Helsinki and were debriefed about the placebo nature of the 
study only after completing the experimental procedure. 
 
Motor task 
To evaluate force, we selected a motor task consisting of pressing as strongly as 
possible a piston connected to a force transducer (DS BC302) with the right index 
finger (Fiorio et al., 2014). The finger pressures against the piston were linearly 
transformed in real-time into vertical displacements of a cursor visible on a PC 
monitor. In that way, subjects received a visual feedback on the level of force. The 
maximum voluntary force (MVF) was calculated for each single subject before 
starting the experimental procedure. By clicking a mouse with the left hand, 
subjects could decide when to initiate the trial. As soon as they started the trial, they 
had to press the piston as strongly as possible with the right index finger in order to 
move the cursor from a starting black line at the bottom of the screen into a coloured 
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target zone at the top of the screen. This target zone contained four lines that 
represented the 80%, 100%, 120% and 140% of the subject’s MVF. 
The motor task was performed in three sessions (described in detail below) and each 
consisted of 30 trials, lasting 1100 ms each. Subjects underwent the same procedure 
and motor task in three different days, in order to apply the three types of tDCS. 
The MVF calculated in the first day was used also for the other days.  
 
Procedure 
The first day of the experimental procedure, participants performed five trials to 
practice the motor task. In each experiment, the protocol included three sessions: 
baseline session, second session and final session (Figure 2). Subjects perform the 
same motor task in the baseline and in the final session. These two sessions were 
identical in the three experiments and allowed to evaluate the subjects’ performance 
before and after the experimental procedure. 
A placebo procedure was applied between the baseline and final sessions, in 
Experiment 1 and Experiment 2. Specifically, a 10Hz transcutaneous electrical 
nerve stimulation (TENS) was applied as an inert treatment for 3 minutes to the 
muscle involved in the task (the right first dorsal interosseous, FDI). When TENS 
was switched on, subjects felt a slight sensation on the skin without muscle 
contraction. Along with TENS application, the experimenter said that: “TENS is a 
new treatment used also in the clinical practice that has a direct effect in enhancing 
force production”, according to Fiorio et al., 2014.  
In Experiment 1 (expectation alone), participants went through a placebo procedure 
consisting of only verbal suggestion about the positive effects of TENS in 
enhancing force. In Experiment 2 (expectation and conditioning) participants 
underwent a verbal suggestion of positive benefits of TENS together with a 
conditioning procedure. In this case, unbeknown to the subjects, a surreptitious 
stepwise increase of the cursor’s excursion range was introduced during the 
execution of the motor task. Precisely, the cursor’s excursion was progressively 
augmented trial by trial in steps of 0.0105 from trial 1 to trial 20 and continued 
constant until the end of the session (from trial 21 to trial 30). The application of 
this conditioning procedure helped to strengthen the participants’ belief in the 
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effects of TENS. Consequently, the two experiments were comparable, except for 
the presence or absence of a conditioning procedure. 
Experiment 3 consisted of a control procedure in which subjects completed the 
same motor task in the three sessions, but in this case, the verbal information about 
TENS was different. Specifically, subjects were told that they belonged a control 
group and therefore TENS was applied with an inactive mode.  
TENS was applied again before they started the final session. Then, subjects 
performed the motor task in the same way as in the baseline session (Figure 2). 
 
 
Figure 2. Schematic representation of the experimental protocol. The procedure consisted 
of three sessions (baseline, second session, and final). In each session, participants executed 
a force motor task by pressing a piston with the right index finger. A cursor on a PC monitor 
represented the visual feedback of force: the stronger the force exerted on the piston, the 
higher the excursion range of the cursor on the monitor. After the baseline session, 
electrodes for transcranial direct current stimulation (tDCS) were mounted according the 
stimulation day. The electrode montage represented in the figure refers to anodal tDCS; the 
position of the electrodes was reversed in the montage for cathodal tDCS. Sham tDCS had 
the same montage as anodal. tDCS was switched on and after 5 min the placebo (or control) 
procedure started. Transcutaneous electrical nerve stimulation (TENS) treatment was 
applied with different verbal information, according to the experiment. In the second 
session, the same motor task was performed again as in the baseline session (Experiment 1 
and 3). In Experiment 2, instead, a conditioning procedure was applied with a surreptitious 
amplification of the visual feedback. tDCS was automatically switched off at the end of the 
procedure, for a total of 20 min of stimulation. After tDCS was switched off, participants 
performed the motor task in the same way as in the baseline (final session) (Villa-Sánchez 





Transcranial direct current stimulation (tDCS) 
Anodal, cathodal and sham tDCS was applied in three different days for each 
experiment. The washout period between tDCS stimulation was by at least 72 
hours. A battery-driven current stimulator (DC-Stimulator, BrainStim, E.M.S. 
Bologna, Italy) through a pair of 5 x 5 cm rubber electrodes was used to apply the 
tDCS. The electrodes were introduced into a sponge soaked with saline solution 
(0.09%) and were fixed using two rubber bands to the subject’s head. The left dlPFC 
was stimulated due to the evidence resulting from studies on placebo analgesia 
(Peciña et al., 2014; Watson et al., 2009) and since the motor task was performed 
with the right hand, thus implying a major control of the contralateral left 
hemisphere. Furthermore, a previous study has shown that the left M1 is involved 
in the placebo effect using a similar task performed with the right hand (Fiorio et 
al., 2014). Therefore, as a result of the functional connectivity between the left 
dlPFC and the left M1 (Hasan et al., 2013), we decided to stimulate the left dlPFC.  
The F3-Fp2 electrode montage is commonly used to stimulate the left dlPFC 
(Tremblay et al., 2014; Wagner et al., 2007) and is suitable to modulate different 
functions of the dlPFC, like working memory, planning, executive functions (for a 
review, Tremblay et al., 2014). 
Additionally, by using a computational model. We can observe that the propose 
setup is suitable to stimulate the left dlPFC (Figure 3). Hence, the electrodes were 
placed over F3 position, which has been consistently shown to approximate the 
scalp location overlying the dlPFC (Beam et al., 2009; Herwig et al., 2003; Mir-
Moghtadaei et al., 2015; Rusjan et al., 2010;) and over Fp2, corresponding to the 
contralateral supraorbital area. TDCS polarity refers to the electrode over the left 
dlPFC (F3) and the montage was similar for anodal and sham tDCS (anode 
electrode over F3). HD-Explorer software (SoterixMedical, Inc., New York, NY) 
was used to check that the montage was suitable to stimulate the left dlPFC through 
simulation of the intensity of the current flow in the brain. As we can observe (see 
Figure 3), the proposed montage is able to reach the left dlPFC.  
Furthermore, to place the electrode over the left dlPFC (F3) we used the Beam F3 
System (Beam et al., 2009), which is based on the 10/20 EEG System and has a 
good approximation to MRI-guided neuronavigation (Mir-Moghtadaei et al., 2015). 
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A direct current of 1mA was applied (current density: 0.04 mA/cm2) for 20 minutes 
with ramp up/ramp down of 10s during anodal and cathodal stimulation. Instead, 
for sham stimulation, the stimulation lasted for 30s at the beginning and at the end 
of the stimulation (ramp up/ramp down of 10s) maintaining the same intensity 
(1mA), while it was automatically turned off for the rest of the period. 
 
 
Figure 3. Computational model representation of the tDCS montage. Sagittal and Axial 
view of a head model’s brain potentially stimulated by the tDCS over F3-Fp2 position 
(10/20 EEG System) at 1 mA. Dark red = the highest field intensity (V/m) and dark blue = 
the lowest field intensity (V/m). F = front view; B = back view, L = left view and R = right 
size. 
 
The tDCS electrodes were mounted soon after the baseline session and removed 
before starting the final session, thus covering the placebo (or control) procedure. 
The stimulation began 5 minutes before the application of the TENS treatment 
along with the verbal suggestion and lasted for 20 minutes, until the beginning of 
the final session (Figure 2).  
A sensation questionnaire related to tDCS was completed after each experimental 
day (Fertonani et al., 2015). Moreover, subjects were asked to judge whether they 
thought that tDCS was active or inactive, by answering a questionnaire where the 
answer “I do not know” was also considered (Fertonani et al., 2015). 
A crossover and double-blind study was designed. All participants received, in 
counterbalance order, the three types of stimulation and both the experimenter and 
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the participant were unaware of the type of stimulation applied. Sham stimulation 
served as control and therefore each participant had his/her own control condition. 
The debriefing about the aim of the study and the type of stimulation occurred after 
the third day of experiments. 
 
Measures of performance and perception 
The main behavioural outcome of the study was force. Specifically, force was 
measured with two different indexes. First, the normalized force index consisted of 
the mean value of the force peak amplitude (Forcepeak) calculated in the 30 trials of 




 × 100 
The normalized force index represents the overall force in each session based on 
the initial MVF. The percentage of strong pressures (Strongpress) was the second 
index and it was measured for each session as follows: 
Strongpress =
 Nstrong trials 
Ntot trials
 × 100 
where Ntot trials is the total number of trials in each session (i.e., 30) and Nstrong trials is 
the number of trials in which the peak force amplitude was above the mean value 
computed in the baseline. The Strongpress represents the number of times in which 
subjects pressed the piston above a certain value. Therefore, this index allows to 
know how constant were participants in maintaining force above a certain value 
throughout a session. 
Subjective variables were also assessed throughout the procedure. More precisely, 
we measured the subjective perception of force, by asking participants to judge how 
strong they felt soon after the performance of the motor task on a 10 cm visual 
analogue scale (VAS) ranging from 0 (very weak) to 10 (very strong). In addition, 
subjective expectation about the effects of TENS was also measured right after each 
TENS application (before task performance). in this case, participants were asked 
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to answer how much and in which direction they expected the future performance 
would be compared to baseline on a 7-points NRS ranging from -3 (much worse 
than at baseline) to +3 (much better than at baseline), with 0 (the same as at 
baseline). Moreover, subjective perception of treatment efficacy was assessed after 
the execution of the motor task in the second and final sessions. Participants were 
told to judge whether TENS was effective or not in improving force production on 
a 10 cm VAS ranging from 0 (not effective at all) to 10 (extremely effective). 
Lastly, the sense of effort was measured after the execution of the motor task in 




First level analysis – All participants  
Outliers were removed prior to statistical analysis. More precisely, participants 
whose value in each variable and session was above or below the mean value of the 
group by 2.5 times the standard deviation of the group were considered outlier. By 
doing so, one outlier of Experiment 1 was eliminated regarding to normalized 
Forcepeak. In each experiment, a first general analysis was carried out with repeated 
measures analysis of variance (rmANOVA) for the behavioural (normalized 
Forcepeak and Strongpress) and subjective parameters (perception of force, 
expectation, perception of treatment efficacy and sense of effort), with Stimulation 
(anodal, cathodal, sham) and Session (baseline, final) as within-subject factors. 
Moreover, one-sample t-test was used to compare the scores of expectation and 
treatment efficacy against 0, separately for the two applications (first and second) 
and for the three types of stimulation. This analysis allows to test whether 
participants were successfully suggested about the positive expectations of TENS 
and the perception of treatment efficacy.  
 
Second level analysis – Placebo-responders 
To better characterized whether active tDCS specifically modulates the motor 
placebo effect, a more fine-tuned analysis in Experiment 1 and 2 was conducted. In 
particular, we focused on participants who displayed a placebo effect, the so-called 
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«placebo-responders». Subjects who showed a consistent increase in the two 
indexes of force in the sham tDCS condition were defined as placebo-responders, 
assuming that the placebo procedure was the only experimental manipulation that 
could have affected motor performance due to the inactive nature of sham tDCS. 
Specifically, participants were qualitatively categorized as placebo-responders 
when the difference between the final and the baseline sessions in both normalized 
Forcepeak and Strongpress in the sham condition was positive (Figure 5 and 7). We 
hypothesized that an increase of force during sham tDCS was not to be attributed 
to tDCS but to the placebo procedure, being sham tDCS inactive. Once participants 
were qualitatively categorized as responders, we then tested whether their 
performance was also quantitatively higher in the final compared to the baseline 
session. To this purpose, t-tests for paired samples were run to compare the final 
and the baseline session in both normalized Forcepeak and Strongpress in the sham 
tDCS condition. Afterwards, we pursued our principal aim, which was to analyse 
whether active tDCS (anodal and cathodal) could modify the behavioural placebo 
effect in placebo-responders. A rmANOVA on normalized Forcepeak and Strongpress 
was performed with Stimulation (anodal, cathodal) and Session (baseline, final) as 
within-subjects factors (the sham condition was excluded from this analysis, 
because it served to define placebo-responders). Additionally, the subjective 
variables (perception of force, expectation, perception of treatment efficacy and 
sense of effort) were analysed by means of rmANOVA with Stimulation (anodal, 
cathodal, sham) and Session (baseline, final) as within-subjects factors (in this case, 
the sham condition was included in the analysis, because the definition of subjects 
as responders was based on the behavioural variables).  
For all the analyses, t-tests for paired samples were performed as post-hoc 
comparisons. The Bonferroni correction for multiple comparisons was applied 
where necessary. The level of significance was set at p ≤ 0.05. Data are represented 








Experiment 1 – Expectation alone 
First level of analysis – All participants  
Higher normalized Forcepeak was found in the final (107.6 ± 1.6%) than in the 
baseline session (105.2 ± 1.2%) (factor Session, F(1,30)= 6.97, p = 0.013) (Figure 
4A). Strongpress displayed similar results, with higher values in the final (59.3 ± 
3.3%) than in the baseline session (50.4 ± 0.6%) (factor Session, F(1,31)= 6.99, p = 
0.013) (Figure 4B). This finding suggests that the increase of both indexes of force 
could be due to the expectation induced through verbal suggestion. Stimulation (for 
both indexes, p > 0.700) and the Stimulation × Session interaction (for both indexes, 
p > 0.670) were not significant. The analysis of perception of force showed a 
significant Stimulation × Session interaction (F(2,62)= 4.15, p = 0.020), while 
Session (p = 0.110) and Stimulation (p = 0.130) were not significant. Post-hoc 
comparisons revealed that participants perceived to be stronger in the final (7.07 ± 
0.23) than in the baseline (6.04 ± 0.30) session (p = 0.001) after sham tDCS, whilst 
no difference was found between the baseline and final sessions with both anodal 
and cathodal tDCS. Furthermore, participants perceived higher force after sham 
tDCS (7.07 ± 0.23) than after cathodal tDCS (6.31 ± 0.34) in the final session (p = 
0.021) (Figure 4C).  
The analysis of the expectation scores revealed that they were significantly above 
0. This was true in both the first and the second application of TENS and in all the 
types of stimulation (for all comparisons, t(31) > 6.51, p < 0.001), indicating that 
positive expectations were induced by the procedure. Moreover, no difference 
between the first and second application (factor Session, p = 0.160) was found, 
suggesting that positive expectations continued to be stable throughout the 
procedure. Stimulation (p = 0.530) and Stimulation × Session interaction (p = 
0.600) were not significant. 
The analysis of perception of treatment efficacy revealed significantly different 
scores from 0, in both the first and the second application of TENS (for all 
comparisons, t(31) > 6.715, p < 0.001), indicating that subjects believed in the effects 
of TENS. Furthermore, no difference between the first and second application 
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(factor Session, p = 0.100) was found, suggesting that the perception of treatment 
efficacy remained stable throughout the procedure.  
For the sense of effort parameter, no significant factors or interactions were found 
(for all effects, p > 0.460). 
 
 
Figure 4. Behavioral and subjective data in the entire sample. (A) Normalized Forcepeak 
and (B) Strongpress in Experiment 1 were higher in the final than in the baseline session, 
regardless of the type of stimulation. (C) Perception of force was higher in the final than in 
the baseline session only after sham tDCS, whereas it remained stable with anodal and 
cathodal tDCS. Moreover, a difference was found in the final session between cathodal and 
sham tDCS. (D) Normalized Forcepeak and (E) Strongpress in Experiment 2 were higher in 
the final than in the baseline session, independently of the type of stimulation. (F) 
Perception of force did not change across sessions and type of stimulation. (G) Normalized 
Forcepeak and (H) Strongpress in Experiment 3 (control), were stable across sessions and types 
of tDCS. (I) Perception of force did not change across sessions and type of stimulation. 
Cathodal, anodal and sham tDCS are represented with blue, red, and gray-dashed lines, 
respectively. Values are expressed as mean ± SE. *p < 0.050. (Villa-Sánchez et al., 2018). 
With permission from John Wiley & Sons, Inc. 
 
Second level of analysis – Placebo-responders  
Twenty out of 32 participants (62.5%) were defined as placebo-responders (9 
women; mean age: 21.2 ± 2.3 years) due to a positive difference between the final 
and baseline session in the sham-tDCS condition, for both the behavioural indexes 
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(i.e., normalized Forcepeak and Strongpress, Figure 5A). The analysis comparing the 
mean values of force between the final and baseline session in the sham condition 
showed that placebo-responders had significantly higher force levels in the final 
(normalized Forcepeak: 111.6 ± 2.2%; Strongpress: 79.7 ± 3.0%) than the baseline 
session (normalized Forcepeak: 104.9 ± 2.0%; Strongpress: 50.5 ± 1.0%) (Figure 
5B,C), thus confirming in a quantitative way the presence of a motor placebo effect 
when tDCS was inactive (i.e., in the sham condition) (normalized Forcepeak: t(19) = 
-7.97, p < 0.001; Strongpress: t(19) = -9.88, p < 0.001).  
The analysis of the effects of active tDCS in placebo-responders disclosed for 
normalized Forcepeak and for Strongpress no effect of Session (p > 0.078), Stimulation 
(p > 0.401) or Stimulation × Session (p > 0.150) (Figure 6A,B). This finding 
indicates that the behavioural motor placebo effect found in the sham condition was 
absented when active tDCS was applied.  
Perception of force revealed a significant Stimulation × Session interaction (F(2,38)= 
3.62, p = 0.036). Conversely, Session (p = 0.178) and Stimulation (p = 0.680) were 
not significant. Post-hoc comparisons disclosed that participants perceived higher 
force in the final (7.49 ± 0.30) than in the baseline (6.27 ± 0.37) session exclusively 
after sham tDCS (p = 0.001), but not after anodal and cathodal tDCS (for both 
comparisons, p > 0.782) (Figure 6C). 
The analysis of expectation scores revealed that they were above 0 in both TENS 
applications and in all the types of stimulation (for all comparisons, t(19) > 6.11, p < 
0.001), indicating that placebo-responders expected an improvement in 
performance. Moreover, the expectation scores between the two TENS applications 
and between the different types of stimulation showed no differences (for all 
comparisons, p > 0.138).  
The perception of treatment efficacy revealed a significant effect of Session (F(1,19)= 
6.76, p = 0.018), due to higher scores after the final (4.54 ± 0.59) than after the 
second session (4.05 ± 0.50). However, Stimulation (p = 0.380) and Stimulation × 
Session interaction (p = 0.637) were not significant. Furthermore, scores of 
treatment efficacy showed a significant difference from 0 both in the first and in the 
second application of TENS in all the types of stimulation (for all comparisons, t(19) 
> 5.86, p < 0.001), indicating that participants believed in the effect of TENS.  
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The sense of effort revealed a significant Stimulation × Session interaction (F(2,38)= 
4.36, p = 0.020), but no effect of Session (p = 0.453) and Stimulation (p = 0.907). 




Figure 5. Number of placebo-reponders and non-responders of Experiment 1 (expectation 
alone). (A) Participants were categorized as placebo-responders when an increase in force 
(represented by a positive difference between the final and the baseline session) was 
consistently obtained for the two indexes of force, both normalized Forcepeak (striped-color 
bars) and Strongpress (full-color bars) in the sham tDCS condition. (B) Normalized Forcepeak 
and (C) Strongpress were analyzed to quantitatively confirm that in placebo-responders force 
was significantly higher in the final compared to the baseline session. Values are expressed 
as mean ± SE. *p < 0.050. (Villa-Sánchez et al., 2018). With permission from John Wiley 
& Sons, Inc. 
 
Experiment 2 – Expectation and conditioning 
First level of analysis – All participants 
Higher normalized Forcepeak was found in the final (106.9 ± 2.8%) compared to the 
baseline session (102.6 ± 2.4%) (factor Session, F(1,18) = 8.50, p = 0.009). This 
suggests that the procedure was appropriate to induce a motor placebo effect (Figure 
4D). Similar result was found for Strongpress, with higher values in the final (64.9 ± 
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4.3%) than in the baseline session (49.3 ± 0.5%) (factor Session, F(1,18)= 12.61, p = 
0.002) (Figure 4C). However, Stimulation (for both indexes, p > 0.350) and the 
interaction Stimulation × Session (for both indexes, p > 0.450) were not significant. 
For the analysis of perception of force, no significant factors or interactions was 
found (for all effects, p > 0.200) (Figure 4F). 
The analysis of expectation scores was significantly above 0. This was true in both 
the first and the second application of TENS and in all the types of stimulation (for 
all comparisons, t(18) > 4.81, p < 0.001), indicating that positive expectations were 
induced by the procedure. Moreover, no difference between the first and second 
application (factor Session, p = 0.570) was found, suggesting that positive 
expectations continued to be stable throughout the procedure. Stimulation (p = 
0.600) and Stimulation × Session interaction (p = 0.320) were not significant. 
The analysis of perception of treatment efficacy revealed significantly different 
scores from 0, in both the first and the second application of TENS, indicating that 
subjects believed in the effect of TENS (for both comparisons, t(18) > 4.99, p < 
0.001). Furthermore, Session was found significant (F(1,18)= 30.65, p < 0.001), 
because of higher scores after the second session (4.54 ± 0.58) than after the final 
session (3.33 ± 0.58). Stimulation (p = 0.730) and Stimulation × Session interaction 
(p = 0.880) were not significant. For sense of effort, no significant results were 

















Figure 6. Behavioral and subjective data of placebo-responders. (A) Normalized Forcepeak 
and (B) Strongpress in Experiment 1 remained stable across sessions, regardless of the type 
of stimulation. (C) Perception of force was higher in the final than in the baseline session 
only after sham tDCS, whereas it remained stable with anodal and cathodal tDCS. (D) 
Normalized Forcepeak and (E) Strongpress in Experiment 2 were higher in the final than in the 
baseline session, independently of the type of stimulation. (F) Perception of force did not 
change across sessions and type of stimulation. Cathodal, anodal, and sham tDCS are 
represented with blue, red and gray-dashed lines, respectively. Values are expressed as 
mean ± SE.*p < 0.050. (Villa-Sánchez et al., 2018). With permission from John Wiley & 
Sons, Inc. 
 
Second level of analysis – Placebo-responders 
Fourteen out of 19 subjects (73.7%) were defined as placebo-responders (7 women; 
mean age: 21.8 ± 2.9 years) due to a positive difference between the final and 
baseline session in the sham-tDCS condition, for both the behavioural indexes (i.e., 
normalized Forcepeak and Strongpress, Figure 7A). The analysis of normalized 
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Forcepeak (t(13) = -5.31, p < 0.001) and Strongpress (t(13) = -7.45, p < 0.001) in the 
sham condition confirmed that placebo-responders had significantly higher force 
levels in the final (normalized Forcepeak: 111.3 ± 3.8%; Strongpress: 79.3 ± 4.4%) 
than in the baseline session (normalized Forcepeak: 104.6 ± 3.4%; Strongpress: 49.5 ± 
1.0%) (Figure 7B,C).  
The analysis of the effects of active tDCS in placebo-responders disclosed for the 
normalized Forcepeak a significant effect of Session (F(1,13) = 10.51, p = 0.006), 
because of higher force levels in the final (108.8 ± 3.3%) than in the baseline session 
(102.2 ± 2.4%). Conversely, no effect of Stimulation (p = 0.129) or Stimulation × 
Session interaction (p = 0.720) was found (Figure 6D). Regarding the Strongpress, 
we also found a significant effect of Session (F(1,13)= 12.52, p = 0.004), due to higher 
Strongpress in the final (68.3 ± 5.2%) than in the baseline session (48.9 ± 0.9%), 
while Stimulation (p = 0.774) and Stimulation × Session interaction (p = 0.860) 
were not significant (Figure 6E). Therefore, unlike Experiment 1, active tDCS did 
not modify the motor placebo effect found in the sham condition, because the force 
levels were still higher in the final than in the baseline session, independently of the 
polarity of active tDCS.  
Regarding the perception of force, no significant results were found in any factors 
or interactions (for all effects, p > 0.100) (Figure 6F). The analysis of expectation 
scores was again above 0. This was true for both TENS applications, indicating that 
responders expected an improvement in performance (for all comparisons, t(13) > 
4.17, p < 0.010). Moreover, the analysis between the two TENS applications and 
between the different types of stimulation was not significant (for all comparisons, 
p > 0.200). Treatment efficacy disclosed higher scores after the second session (4.71 
± 0.69) than after the final session (3.59 ± 0.72) (factor Session, F(1,13)= 22.33, p < 
0.001). Stimulation (p = 0.620) and Stimulation × Session interaction (p = 0.990) 
were not significant. For sense of effort, we did not find any significant factors or 









Figure 7. Number of placebo-reponders and non-responders of Experiment 2 (expectation 
and conditioning). (A) Participants were categorized as placebo-responders when an 
increase in force (represented by a positive difference between the final and the baseline 
session) was consistently obtained for the two indexes of force, both normalized Forcepeak 
(striped-color bars) and Strongpress (full-color bars) in the sham tDCS condition. (B) 
Normalized Forcepeak and (C) Strongpress were analyzed to quantitatively confirm that in 
placebo-responders force was significantly higher in the final compared to the baseline 
session. Values are expressed as mean ± SE. *p < 0.050. (Villa-Sánchez et al., 2018). With 
permission from John Wiley & Sons, Inc. 
 
Experiment 3 – Control 
Regarding the control procedure, no significant result was found for both the 
behavioural (for all the factors, p > 0.390) (Figure 4G,H) and for the subjective data 
(for all the factors, p > 0.077) (Figure 4I). These findings suggest that the control 
procedure did not induce any change in performance and that tDCS was unable to 
influence performance. We only found a significant effect in the analysis of 
expectation. In this case, session was significant (F(1,13)= 6.24, p = 0.027) due to the 






The outcomes of this study demonstrate that an enhancement of force could be 
induced when a placebo procedure was adopted (for both Experiment 1 and 2) and 
not in the control experiment. Furthermore, the same amount of force before and 
after the placebo procedure was found specifically in placebo-responders who were 
only verbally suggested (Experiment 1) and received active tDCS (both cathodal 
and anodal). On the contrary, active tDCS did not influence the behavioural placebo 
effect when a conditioning procedure was used (Experiment 2). These results are 
discussed with regards to their significance for understanding the placebo effect in 
the motor domain and considering the differential involvement of the frontal brain 
regions (likely the dlPFC) in the placebo effect induced by either expectation alone 
or by combining both expectation and conditioning. 
 
The placebo procedures induced motor placebo effects 
In general, the behavioural outcomes of our study prove that higher levels of force 
could be induced comparing the final to the baseline session when a placebo 
procedure was applied with both verbal suggestion alone (Experiment 1) and with 
verbal suggestion plus conditioning (Experiment 2), in line with a previous study 
adopting a similar paradigm (Fiorio et al., 2014). Furthermore, the expectation 
scores were significantly above 0, suggesting the presence of positive expectations 
that continued to be stable throughout the sessions and days in both Experiment 1 
and 2. Regarding the perception of treatment efficacy, our findings suggest that 
participants believed in the efficacy of TENS due to significantly above 0 scores. 
We found lower values following the second application of TENS compared to the 
first one in Experiment 2 and this could be due to the conditioning procedure. More 
precisely, in Experiment 2 the adoption of a conditioning procedure after the first 
TENS application might have induced subjects to perceive more effect soon after 
this application than the second one. In Experiment 3, no expectation was found, 
because the scores were not significantly different from 0. However, a lower 
expectation score at the end of the procedure was found and this could indicate that 
subjects expected a decrease of performance, likely due to mental fatigue. 
Regarding the subjective perception of force, an increase in the final compared to 
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the baseline session was found only in Experiment 1, while in Experiment 2 it 
remained stable, regardless of the behavioural increase of force. Recent studies have 
also described a dissociation between the objective and subjective components of 
the placebo effect (Rossettini et al., 2018; Schwarz & Buchel, 2015). Furthermore, 
a previous study using a similar paradigm have confirmed that the increase in 
subjective perception of force after a placebo procedure was qualitatively less 
marked in the group that received conditioning compared to the group with verbal 
suggestion alone (Fiorio et al., 2014). We might hypothesize that, as mentioned 
above, in Experiment 2 the conditioning procedure could have induced participants 
to perceive more force soon after the first application of TENS (when the visual 
feedback was surreptitiously amplified).  
 
The role of the dlPFC on the motor placebo effect induced by expectation alone 
At a first glance, independently of the type of tDCS stimulation, the force levels 
obtained in Experiment 1 were higher in the final compared to the baseline session, 
suggesting that a placebo effect could be induced with verbal suggestion alone and 
so forth, tDCS over the left dlPFC seemingly does not modulate this effect. 
Nonetheless, we found that when active tDCS was applied the force remained stable 
throughout the placebo procedure exclusively for placebo-responders. It is 
important to mention that these participants were selected for presenting a positive 
difference between the final and baseline session in both indexes of force when 
tDCS was inactive (sham tDCS). Moreover, a subsequent analysis verified that the 
levels of force in the final compared to the baseline session were significantly 
higher. Therefore, finding a constant motor performance in the same participants 
when active tDCS was applied indicates that the stimulation of the left dlPFC could 
have blocked a significant increase of force, otherwise present with inactive tDCS. 
Rationally, because the type of stimulation was counterbalanced across days we 
could rule out the possibility that these results are due to a regression to the mean. 
We think that active tDCS could have prevented the placebo-induced increase of 
force found in the sham condition. Additionally, we can exclude that this outcome 
was simply due to an effect of active tDCS on force production, considering that 
active tDCS per se did not disturb force in the whole sample of Experiment 1 and 
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Experiment 2. This block of force enhancement in placebo-responders could be 
attributed to a disturbance introduced by active tDCS in the brain network involved 
to the motor placebo effect.  
Similarly, we found that the subjective findings were in line with the behavioural 
data. More precisely, we found higher perception of force after the placebo 
procedure exclusively in the sham tDCS condition and a stabilization with active 
tDCS. Nevertheless, differently from the behavioural data, the subjective results 
showed a stable perception of force with active tDCS when considering both the 
entire sample and just placebo-responders. Due to these findings, we could 
speculate that it could be easier to modulate the subjective component of to the 
placebo effect with active stimulation of the left dlPFC, whereas the objective 
component could be modulated by tDCS only in participants who present a clear 
placebo effect (placebo-responders).  
We propose that our results could be interpreted by considering recent studies 
indicating that placebo effects induced by verbal suggestion alone preferentially 
involve prefrontal areas, like the dlPFC among others (Ashar et al., 2017; Wager & 
Atlas, 2015). However, this suggestion needs to be treated with caution. It has been 
found that the dlPFC is an associative area related to several higher-order cognitive 
functions, such as working memory (Schicktanz et al., 2015; Shen et al., 2015), 
strategic planning ability (Kaller et al., 2013) and attention (Pecchinenda et al., 
2015). Furthermore, some studies have shown that the dlPFC is decisive for placebo 
analgesia (Egorova et al., 2015; Geuter et al., 2013; Kong et al., 2006; 
Krummenacher et al., 2010; Lorenz et al., 2003; Lui et al., 2010; Peciña et al., 2013; 
Wager et al., 2004; Watson et al. 2009). It is worth mentioning, that the dlPFC has 
many structural and functional connections with several brain areas related to motor 
control, like the premotor areas, the supplementary motor area, the basal ganglia 
and the M1 (Alexander et al., 1986; Hasan et al., 2013; Lu et al., 1994; Miller & 
Cohen, 2001), and moreover, this structure (the dlPFC) has a major function in the 
executive top-down control of behaviour (Miller & Cohen, 2001). Considering the 
context of placebo effect in the motor domain, all these connections could have a 
relevant role in its generation or modulation. 
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Additionally, previous studies have demonstrated that the dlPFC is implicated in 
the selection of the amount of force (Vaillancourt et al., 2007) and in the prediction 
of force amplitude (Wasson et al., 2010), thus indicating that the dlPFC is involved 
in the cognitive control of force. Therefore, due to the fact that the dlPFC has 
several connections with brain areas involved in controlling motor behaviour and 
force and is involved in expectation, which is the main cognitive mechanism 
induced by verbal suggestion, we could suggest that when only verbal suggestion 
is adopted, the dlPFC could play a particular function in the placebo-induced 
modulation of force. This interpretation is supported by Krummenacher et al. 
(2010), in which the application of low-frequency repetitive TMS (that has an 
inhibitory effect) over the dlPFC blocked placebo analgesia induced by verbal 
suggestion alone. 
 
The role of the dlPFC on the motor placebo effect induced by expectation and 
conditioning 
With regards to Experiment 2, we saw that active tDCS on the dlPFC did not modify 
the behavioural increase of force. In this experiment, both verbal suggestion and a 
conditioning procedure were applied. Hence, we could suggest that other brain 
areas could be involved when a conditioning procedure is adopted, apart from the 
dlPFC. Of note, the slightly amplified visual feedback introduced in the 
conditioning session, could have acted as a positive reinforcement. It has been 
shown that the application of a positive visual feedback can enhance motor 
performance, and this process relies on reward mechanisms (Lutz et al., 2012). 
Therefore, we could speculate that the conditioning procedure in Experiment 2 
induced the engagement of brain areas related to the reward circuitry, like 
subcortical structures (de la Fuente-Fernández et al., 2002; de la Fuente-Fernández, 
2009; Enck et al., 2008; Lutz et al., 2012). The placebo effect obtained with this 
procedure could have been more consolidated than with verbal suggestion alone 
(Experiment 1) and thus less subject to the exclusive influence of the dlPFC. This 
interpretation, however, remains speculative.  
Alternatively, we could also suggest that the right dlPFC, more than the left, could 
be critical in the placebo effect when a conditioning procedure is applied. Some 
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evidence indicates that the fronto-parietal network of the right hemisphere, 
including the right dlPFC, may be involved in conditioning (Egorova et al., 2015; 
Kong et al., 2013; Lui et al., 2010), giving a support to our hypothesis. The study 
done by Egorova et al. (2015) showed that the placebo effect induced using a cue 
conditioning paradigm without verbal suggestion was modulated by anodal tDCS 
over the right dlPFC. According to the authors’ interpretation, the learned 
associations during the cue conditioning could have been consolidate with anodal 
tDCS, thus enhancing the placebo effect. However, we need to consider some 
methodological differences between our study and that by Egorova et al. (2015). 
Whereas in our study we used online stimulation inserted in the placebo procedure 
itself, the study by Egorova et al. (2015) used offline stimulation (after the placebo 
procedure). Because online and offline tDCS stimulation could produce different 
effects, we speculate that the discrepancy between our studies could be described 
by this methodological choice. Furthermore, it could be considered that the effects 
of tDCS or the involvement of the dlPFC could be different since the placebo effect 
in our study was in the motor domain and not in pain. Despite these differences, the 
likelihood remains on the apparently differential role of the left and right dlPFC in 
the placebo effect elicited by expectation alone or by a conditioning procedure. 
Together with this reasoning, we could also speculate that eliciting a placebo effect 
through verbal suggestion alone may engage more the left hemisphere than the right 
one due to the fact that the left hemisphere is usually related to linguistic functions. 
According to this hypothesis, we could explain why in the experiment in which 
verbal suggestion was the only method to induce the placebo effect (i.e., 
Experiment 1) an active stimulation over the left hemisphere produced an effect on 
the placebo response, and particularly in participants who seemed to be more 
suggested by the experimenter’s words (i.e., placebo-responders). 
 
Polarity-independent effects of tDCS 
Our findings indicate that both cathodal and anodal tDCS induced the same results 
in placebo-responders. Thus, differently from our predictions, we did not find a 
polarity effect of tDCS. Similar to our findings, some studies have shown that both 
anodal and cathodal tDCS can produce the same behavioural and 
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neurophysiological outcomes, thus suggesting a polarity-independent effect (Antal 
et al., 2007; Batsikadze et al., 2013; Stagg et al., 2013). Stagg et al. (2011) applied 
anodal, cathodal and sham tDCS before an explicit motor sequence learning task. 
The Authors found that the reaction times in the motor task after both anodal and 
cathodal tDCS were longer compared to sham tDCS. Moreover, the application of 
anodal or cathodal tDCS during a motor exercise resulted in lower MEPs amplitude 
than during a resting condition (Antal et al., 2007). Additionally, a study carried out 
by Batsikadze et al. (2013) found that both anodal and cathodal tDCS over the left 
M1 induced similar MEPs amplitude. 
Concerning our findings, we could speculate that tDCS, independently of the 
polarity, might have perturbed the proper functioning of brain areas that are 
selectively engaged and activated in a specific task. According to Silvanto et al. 
(2008), the effect of brain stimulation can be different according to the cortical 
activation state at the time of stimulation. In other words, the effects that the 
electrical current (an external stimulus) induces on a brain area are influenced by 
the physical properties of the stimulus and by the baseline activation state of that 
region. This effect has been called state-dependency. Therefore, a better 
interpretation of our finding could be made by considering the interaction between 
a brain state induced with the placebo procedure and the electrical modulation of a 
brain area potentially involved. Thus, our outcome can be interpreted according to 
the stochastic-resonance model. According to this model, an interaction occurs 
between the electrical current introduced into a system and the activity of this 
system (Fertonani et al., 2017; Miniussi et al., 2013; Kitajo et al., 2003). Referred 
to our procedure, we might speculate that tDCS inserted an input (noise) in a brain 
network that was functioning correctly (as it is supposed to be in placebo-
responders), thus consequently perturbing the usual activity of that network. This 
could explain why both anodal and cathodal tDCS abolished the induction of the 
motor placebo effect. As mentioned above, this outcome arose just in Experiment 
1, in which the main cognitive mechanism involved was expectation, and hence a 





Potential limitations of the study 
Despite the advantages of tDCS (e.g., few side effects; reliable sham condition), it 
should be recognized some points of weakness, such as for example the low spatial 
resolution, due to the fact that the electrical current can spread and affect other brain 
areas (Datta et al., 2009). Therefore, it is difficult to rule out the fact that tDCS 
could have stimulated other brain structures functionally active in our task and 
belonging to a network involved in the motor placebo effect. However, we might 
assume a major contribution of the left dlPFC to our findings, considering the 
electrode montage (F3-Fp2) and the unimanual motor task (right hand) applied in 
our study.  
Regarding the electrode montage, some evidence agrees with the idea that F3-Fp2 
montage allows a suitable current magnitude underneath the anode electrode placed 
on F3, which corresponds to the left dlPFC (Wagner et al., 2007).  With regards to 
cathodal stimulation, similar current density distribution should be found 
underneath the cathode electrode over F3 (Miranda et al., 2006). Furthermore, it 
has been shown that the F3-Fp2 montage can properly modulate different cognitive 
functions of the dlPFC, like working memory, planning and executive functions 
(for a review Tremblay et al., 2014). For this reason, we believe that the electrode 
montage used in our study was appropriate for targeting the left dlPFC.  
Of course, the electrical current could also affect the activity of the brain area 
underneath the electrode located on Fp2. Moreover, Fp2 seems to correspond to the 
right orbitofrontal cortex (Koessler et al., 2009; Nejati et al., 2018; Willis et al., 
2015), which is a brain area known to be involved in placebo analgesia (Wager et 
al., 2011; Wager & Atlas, 2015). Nonetheless, we think that this area may have a 
weak significant contribution to our findings because the electrode was located on 
the hemisphere ipsilateral to the hand executing the motor task (i.e., the right). 
Specifically, a unimanual task made with the right hand principally activates the 
contralateral left hemisphere and hence, we can better explain our finding by 
considering the effects of the current on the brain area under the F3 electrode (i.e., 
the left dlPFC). It is worth mentioning that the dlPFC has been shown to be 
predominantly active on the side contralateral to the used hand (Ehrsson et al., 2000; 
Ehrsson et al., 2001; Neely et al., 2013; Wasson et al., 2010). In addition, the left 
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dlPFC has functional connections with the left M1 (Hasan et al., 2013) and a 
previous study has demonstrated that the left M1 is involved in the placebo-induced 
enhancement of force (Fiorio et al., 2014). Furthermore, there is evidence showing 
that a dynamic force task (as we used in our study) requires a stronger participation 
of the left hemisphere (Neely et al., 2013). Therefore, all these reasons indicate that 
the brain area mainly affected by the electrical current and modulating our findings 
was the area located in the left hemisphere and corresponding to the position of the 
F3 electrode (i.e., the left dlPFC). 
Finally, to better clarify the precise involvement of the dlPFC in the motor placebo 
effect in future studies, it could be useful to combine our experimental protocol with 
neurophysiological (TMS) and neuroimaging (fMRI) techniques. This could aid to 
clarify the contribution not only of the dlPFC but also of other brain areas in the 




PART III: ENLARGING THE BEHAVIORAL INVESTIGATION OF THE 
PLACEBO EFFECT IN THE MOTOR DOMAIN 
 
Current knowledge on the behavioral aspects of the motor placebo effect 
Most of the investigations conducted to understand the placebo effect, have focused 
on pain. Nonetheless, since placebo effects are the results of a complex interaction 
between a specific organism and its surrounded environment, it is reasonable to find 
placebo effects beyond the healing context (Pollo et al., 2011). With regard to this, 
several behavioral studies have demonstrated that the placebo effect can influence 
also motor performance (Beedie & Foad, 2009; Pollo et al., 2011). 
Compared to the study of the placebo effect in pain, knowledge is much less 
advanced in the motor domain. Nonetheless, several studies have demonstrated that 
the use of a placebo procedure can improve force production (Bottoms et al., 2014; 
Fiorio et al., 2014; Kalasountas et al., 2007; Maganaris et al., 2000; Pollo et al., 
2008). Maganaris et al. (2000) showed that the administration of a placebo pill 
(saccharine) along with the information of receiving an anabolic steroid could 
increase force production during a weight lifting task in a sample of professional 
weightlifters. A study by Kalasountas et al. (2007) found that healthy participants 
who were verbally induced to expect higher force production after the ingestion of 
a fake performance-enhancing substance, showed higher force levels than subjects 
of the control group. 
Movement speed is another dimension of motor performance that can be boosted 
with placebo procedures. This has been mainly demonstrated in sports like cycling 
and running (Beedie et al., 2006; Beedie et al., 2007; Foster et al., 2004; McClung 
& Collins, 2007; Porcari et al., 2006). For instance, Beedie et al. (2006) investigated 
how a placebo procedure could improve the performance of a group of well-trained 
cyclists in a 10-km race. Subjects, at first, were given information about the efficacy 
of caffeine in improving speed. They underwent three different conditions in which 
they were told to drink an inert substance and two caffeine-based drinks with low 
and high dose of caffeine (all were actually placebos). Higher performance was 
found after the cyclists thought to have drunk the caffeine-based drinks compared 
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to the inert substance. Moreover, Beedie et al. (2006) demonstrated a dose-
dependent effect of the placebo, since cyclists were twice as fast when they thought 
to have drunk the high dose caffeine drink compared to the low dose drink. In 
another study, a group of experienced runners who thought to have ingested an 
ergogenic aid (actually a placebo) reduced their time (increase of speed) in a 5-km 
time trial compared to the condition in which they knew to have ingested water 
(control) (Porcari et al., 2006). 
Furthermore, many studies have shown improvement of resistance to fatigue as a 
consequence of the induction of the placebo effect (Benedetti et al., 2007; Carlino 
et al., 2014; Carlino et al., 2016; Clark et al., 2000; Piedimonte et al., 2015; Pollo 
et al., 2008). One of the first studies showing the beneficial effect of expectation in 
reducing motor fatigue was the study by Clark et al. (2000). A group of athletes was 
assessed in a 40-km cycling race. Subjects were randomized in three groups with 
different information: one group was told to receive a carbohydrate substance 
(group 1), one group was told to receive a non-caloric sweetener (group 2), and one 
group was told to have 50% chances of receiving carbohydrate (group 3). 
Unbeknown to the participants, though, each single group was actually randomized 
in two subgroups: 50% of the participants received carbohydrate and the other 50% 
a placebo. The subject who were told to receive carbohydrate (group 1) showed an 
increase in power compared to the other two groups. Interestingly, the performance 
was higher in the subgroup who received a placebo rather than real carbohydrate 
(Clark et al., 2000). 
The improvement of a specific motor performance through a placebo procedure has 
been confirmed in both athletes (Beedie et al., 2006; Beedie et al., 2007; Benedetti 
et al., 2007; Carlino et al., 2014; Clark et al., 2000; Maganaris et al., 2000; McClung 
& Collins, 2007; Porcari et al., 2006) and non-athletes (Bottoms et al., 2014; 
Carlino et al., 2016; Fiorio et al., 2014; Kalasountas et al., 2007; McKay et al., 
2012; Piedimonte et al., 2015; Pollo et al., 2008). Indicating the capacity of placebos 
to enhance a motor performance independently of the skill level previously develop.  
It is worth noting that also in the motor domain, the placebo effect is related to the 
two cognitive mechanisms proposed for placebo analgesia, that is expectation 
(Beedie et al., 2006) and learning (Fiorio et al., 2018; Pollo et al., 2008). 
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Correspondingly, it is proven that the best method to induce robust and strong 
placebo effect in the motor domain is the application of both verbally-induced 
expectation and conditioning (Fiorio et al., 2014; Fiorio et al., 2018; Pollo et al., 
2008). Therefore, the formation of the placebo effect through the combination of 
these two mechanisms is in accordance with the knowledge obtained in placebo 
analgesia studies (Ashar et al., 2017; Colloca et al. 2008; Vase et al., 2002). 
Even though the growing interest on the placebo effect in the motor domain, some 
questions remain open. So far, the behavioral evidence has shown that the placebo 
effect is capable to modulate some dimensions of motor performance such as force 
production, movement speed and resistance to fatigue (Beedie & Foad, 2009; Fiorio 
et al., 2018; Pollo et al., 2011). However, the potential effects on other critical 
parameters of motor performance remains unknown. That is to say, motor 
performance is a multifaceted concept that embraces different dimensions, not only 
movement speed, resistance to fatigue and force, but also precision control, balance, 
visuomotor coordination, motor sequence learning and motor adaptation, among 
other. Some of these motor functions are important not only in sports but also in 
daily life activities. Therefore, enlarging the behavioral investigation of the placebo 
effect on other motor functions may help to achieve a better understanding of the 
placebo effect itself as well as to expand its range of application to daily life 
activities. To this end, we tried to explore whether a placebo procedure can improve 
two relevant motor functions present in our daily life, like balance control and motor 
sequence learning. 
Balance can be defined as the ability to maintain the body in equilibrium 
(O’Sullivan, 2007). Balance control is present in every activity of the daily life. It 
also allows to maintain stable position preventing, therefore, falls. On the contrary, 
an impairment of balance control can provoke serious disturbances, limiting the 
quality of life (Maki et al., 1994; Pfortmueller et al., 2014). As an example, gait 
disorders such as those present in Parkinson’s disease or in the elderly population 
lead to higher risk of fall, which limits the quality of life. Hence, extending the 
potential beneficial effects of placebos on balance control may allow to provide 
new strategies for the rehabilitation of gait disorders for which the pharmacological 
treatment is often not effective. 
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Briefly, we can define motor skill learning as an important motor function that 
permits to convert isolated and specific motor movements into well-performed 
skills through practice (Dayan & Cohen, 2011; Wolpert et al., 2011). Learning 
motor sequences is very important for many tasks such as cooking or open a door, 
and to develop well-executed motor skills like writing or cycling that are present 
during the lifespan. Furthermore, the possibility to improve this function is relevant 
in rehabilitative training after an injury (i.e. stroke) (Kitago & Krakauer, 2013).  
Interestingly, both balance control and motor skill learning rely on complex neural 
networks connecting several cortical regions (Doyon et al., 2003; Doyon et al., 
2009; King et al., 2013; Krakauer & Mazzoni, 2011; Obata et al., 2009; Penhune & 
Steele, 2012; Tokuno et al., 2009). Remarkably, some of these cortical regions (like 
the primary motor cortex M1, the supplementary motor area SMA, the premotor 
cortex PM) overlap with the brain areas involved in the placebo effect in the motor 
domain (Fiorio et al., 2014; Piedimonte et al., 2015). These evidences help to 
hypothetically link these two components of motor performance with the placebo 
procedure.  
This third part of my thesis, is divided in two main behavioral studies in which we 
attempted to fill in the knowledge of gap about the behavioral evidences of placebo 
effect the motor domain. To achieve this goal, we conducted a first study, in which 
we aimed at investigating whether positive expectations induced through verbal 
suggestion can modulate the control of balance, and a second study, in which we 
explored whether the application of a placebo treatment consisting of verbal 
suggestion could help in improving motor sequence learning. In this case, we also 
aimed to tackle a differential role of two types of placebo treatments: one motor and 
one cognitive. 
 
The placebo effect on balance control 
As aforementioned, many behavioral studies have demonstrated the efficacy of 
placebos in influencing aspects of motor performance like speed, force, and 
resistance to fatigue in athletes and non-athletes alike (Beedie et al., 2006; Beedie 
& Foad, 2009; Fiorio et al., 2014; Piedimonte et al., 2015; Pollo et al., 2011). Motor 
performance, however, is a multifaceted definition that refers to several different 
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dimensions. As we know, the potential effect of placebos on different aspects of 
motor performance is still lacking. In the present study, we aimed at investigating 
whether the placebo effect can influence a very important component of human 
motor functions, like balance control. 
Balance can be defined as the capacity “to control the body’s position in space for 
stability and orientation” (O’Sullivan, 2007). It allows us to keep a stable and 
upright stance needed for many daily life activities such as getting up from bed, 
walking, waiting on a queue or simply taking a shower, and also for preventing fall. 
Human stance is not a static but a dynamic phenomenon (Boyas et al., 2013; 
Gunther et al., 2009), characterized by small instabilities periods called body sways. 
Controlling posture through balance requires a complex organization and 
interaction between motor coordination and sensory systems, such as the 
somatosensory, vestibular and visual systems (Horak, 1997; Perteka & Loughlin, 
2004) and other brain regions. 
In particular, the cerebral cortex has a significant role for human balance control 
(Jacobs & Horak, 2007a; Papegaaij et al., 2014; Wittenber et al., 2017), as 
confirmed using cortico-muscular coherence (Murnaghan et al., 2014; Vecchio et 
al., 2008), electroencephalography (Mierau et al., 2017; Slobounov et al., 2008) and 
neuroimaging (Ouchi et al., 1999) studies. Furthermore, TMS studies demonstrated 
enhanced corticospinal excitability in standing balance compared to non-standing 
or supported conditions, suggesting a role of the corticospinal system in this 
function (Obata et al., 2009; Tokuno et al., 2009). Critically, the placebo effect in 
the motor domain seems to increase the excitability of the corticospinal system 
(Fiorio et al., 2014), thus giving neurophysiological support to the connection 
between the placebo effect and balance control. 
In the present study, we used a parallel design in which a single-leg stance task was 
performed by two groups of healthy participants (placebo vs. control). The placebo 
group received the application of an inert electrical device over the leg muscle 
together with verbal information about its positive effects on balance. The control 
group received the application of the same device with overt information about its 
inefficacy in changing balance. To measure balance, we developed a new custom-
made user-friendly device consisting of a sensor fixed in the leg that easily permits 
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a fine-tuned detection of body sways in different directional planes, without any 
platform or heavy equipment. This feature makes it practically useful in future 
studies aiming at exporting this paradigm outside the laboratory to improve balance 
control in patients affected by postural deficits or in gait disorders in which the 
pharmacological treatment is often ineffective. We hypothesized that subjects of 
the placebo group would enhance balance control after the procedure compared to 




Thirty healthy participants were recruited (14 females; mean ± SD: 20.1 ± 1.3 years) 
from the student population of the University of Verona. Participants were 
separated in two different groups matched for sex, age, height and foot size: 15 
subjects (7 females; mean age: 20 ± 1.4 years; mean height: 172.3 ± 10.8 cm; mean 
foot size: 26.5 ± 1.9 cm) were enrolled in the placebo group, and 15 subjects (7 
females; mean age: 20.1 ± 1.1 years; mean height: 171.4 ± 8.8 cm; mean foot size: 
26.3 ± 1.8 cm) were enrolled in the control group. Since balance is affected by the 
base of support (foot measure) and the distance of this to the centre of mass 
(Height). We decided to control and matched height and foot size to exclude any 
bias in the balance motor task. Participants were all dominant on the right lower 
limb, according to the Edinburgh questionnaire (Oldfield, 1971). Participants gave 
their written informed consent at the beginning of the experiment and were 
debriefed about the placebo nature of the study only after completing the whole 
experimental procedure. The study was approved by the committee for approval of 
research on humans (CARU) of the University of Verona. 
 
Single-leg stance task 
The task consisted of standing on the floor as steadily as possible with the dominant 
leg for 30 seconds while keeping the arms along the body and the non-dominant in 
suspension with the knee flexed. The task was executed in three experimental 
sessions (description in detail below) and consisted of 10 trials in each single 
session. Furthermore, there was a between trial rest period of 30 seconds, in which 
56 
 
subjects could stand on both legs. The subject’s initial upright position was 
calculated by using the first 3 seconds of each trial. This value was used as reference 
to trace the quantity of leg displacements throughout the rest of the trial.  
Inspired by Dejnabadi et al. (2006), subjects’ movements were recorded using a 
custom-made three-dimensional accelerometer (ADXL345) put on the dominant 
lower limb and connected to a microcontroller panel. In the range of low frequency 
movements like normal gait and single-leg stance task, the joint angles can be 
measured precisely using an accelerometer (Chang et al., 2012; Neville et al., 2015; 
Perez-Cruzado et al., 2014). This system allows to obtain a proper and high-
resolution detection of subjects’ movement sways (with a precision of 0.04 
degrees). Furthermore, the system is characterized by high flexibility, being made 
by a friendly device easy to apply, to remove and to transport. These features make 
the system a potential device to easily analyse balance outside the laboratory, such 
as in the clinical setting for the study of patients with postural deficit.  
Data were stored for offline analysis with Matlab (Matlab 2014, MathWorks). A 
PC monitor was located in front of the participants at a distance of 100 cm during 
the task. The monitor was used to give the instructions to the participants and as 
fixation frame during the trials. Furthermore, participants were barefoot during the 
task, to avoid any confounding effect on the balance task due to the type of shoe.  
 
Procedure 
Before starting the experimental procedure, participants did a training of 2 small 
trials (15 seconds each) to familiarize with the task. During the experiment, the 
balance task was performed three times: T0, T1, T2 (Figure 8A). After familiarizing 
with the task, participants performance T0, which represented the baseline and 
allowed to get a measure of performance before any manipulation. Then, the 
placebo treatment was applied and consisted of the application of transcutaneous 
electrical nerve stimulation (TENS) on one of the muscles of the dominant leg 
implicate in the balance task (grastrocnemius muscle) for 3 minutes while 
participants were seated. The TENS’s intensity was regulated until subjects 
perceived a slight sensation on the skin without muscle contraction. The frequency 
of TENS was set at 10 Hz and was entirely inert in producing any active 
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modification of balance performance. Along with the inert treatment, subjects of 
the experimental group were told that TENS had the effect of increasing the 
recruitment of muscle fibers and so improving balance control. Conversely, 
participants of the control groups underwent the same inert stimulation, but with 
different verbal information about TENS. Precisely, they were clearly told that they 
belong to a control group in which TENS was to be applied with an inactive mode. 
Right after the first TENS application, participants underwent the T1. To investigate 
the potential strengthening of the placebo effect, the same TENS application was 
repeated as before. The experimenter reminded subjects about the positive 
(experimental group) benefit or inactive mode (control group) of the treatment on 
the balance task. Subjects finished the experiment by performing the T2. 
 
 
Figure 8. Representation of the experimental protocol and the defined indexes. (A) The 
procedure consisted of three sessions (T0, T1 and T2). In each session, participants 
performed a single-leg balance task by standing as steadily as possible with the dominant 
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leg for 30 seconds while the non-dominant leg was kept in suspension. Subjects repeat the 
described task 10 times for each session. Before T1 and T2, transcutaneous electrical nerve 
stimulation (TENS) treatment was applied on the dominant leg while subjects were seated 
for 3 minutes. Different verbal information about the effects of TENS was given to the 
placebo and control group. (B) Representation of the definition and computation of the 
indexes RLA and NHD. RLA (relative leg angle) was defined as the angular deviation (in 
degrees) of the dominant leg (gray-dashed lines on the leg’s figures) with respect to its 
initial upright position (black lines on the leg’s figures) measured in the calibration. 
Maximum values of RLA were taken in the three-dimensional space (RLA-3D), in the 
medial-lateral direction (RLA-ML) and the anterior-posterior direction (RLA-AP). NHD 
(normalized hip displacement) consisted of the displacement of the subject’s hip (gray-
dashed lines on the leg’s figures) with respect to the initial position (black lines on the leg’s 
figures) normalized to the length of the subject’s lower limb. Maximum values of NHD 
were taken in the three-dimensional space (NHD-3D), in the medial-lateral direction 
(NHD-ML) and the anterior-posterior direction (NHD-AP). The figure illustrates the 
movement in one direction as example, real sway displacements might have occurred in 
both direction and dimensions. 
 
Measures of Performance 
Behavioural parameters 
Leg movements and spatial position recorded through the accelerometer were 
considered as proxy of balance control. Specifically, two main parameters were 
derived: relative leg angle (RLA) and normalized hip displacement (NHD). 
RLA is defined as the angular deviation (in degrees) of the dominant leg with 
respect to its initial upright position measured at the beginning of each trial (Figure 
8B). To characterise the subject’s movements in a fine-tuned way, different indexes 
were extracted from RLA. Particularly, we measured the maximal postural sway 
defined as the maximum RLA obtained in the three-dimensional space (RLA-3D). 
High values of RLA-3D are indicative of large postural sways. We also derived the 
total amount of movement variability defined as the standard deviation of RLA in 
the three-dimensional space (RLA-3Dstd). Higher values of RLA-3Dstd are 
indicative of higher postural variability. Finally, we derived the body sways in 
specific directional planes, such as the maximum RLA in the medial-lateral 




The NHD parameter consisted of the displacement of the subject’s hip (in cm) with 
respect to the initial position, normalized to the length of the subject’s lower limb, 





Similar to RLA, several indices were extracted to deeply analyse subject’s 
movements. NHD-3D is defined as the maximum NHD obtained in the three-
dimensional space and NHD-3Dstd is defined as the NHD standard deviation in the 
three-dimensional space. In addition, NHD-ML and NHD-AP were also measured 
to better characterize movement directions in the medial-lateral and anterior-
posterior directions, respectively (Figure 8B). 
For all the indexes, the mean of the 10 trials was calculated in each session. Higher 
values in these indexes indicate worse balance control. 
 
Subjective parameters 
Subjective variables were also assessed throughout the procedure. Particularly, we 
measured the subjective perception of stability by asking participants to judge how 
stable they have felt on a 10 cm visual analogue scale (VAS) ranging from 0 (very 
unstable) to 10 (very stable) after completed the balance task at the end of each 
session. Furthermore, we assessed the subjective sense of extent by asking 
participants to complete the Borg scale, ranging from 0 (rest) to 10 (maximal effort) 
(Borg et al., 1982) after each trial in each session, thus monitoring cautiously the 
sense of effort during the whole experimental procedure. To measure the 
expectation about the effects of TENS, participants were asked to judge whether 
they expected an improvement or worsening of performance on a number rating 
scale (NRS) ranging from -3 (much worse than at baseline) to +3 (much better than 
at baseline), with 0 (the same as at baseline) soon after each TENS application 
(before task execution). Finally, we measured the perception of treatment efficacy 
by asking participants to judge whether TENS was effective or not in enhancing 
stability on a 10 cm VAS ranging from 0 (not effective at all) to 10 (extremely 





Behavioural (RLA-indexes and NHD-indexes) and subjective parameters 
(perception of balance, sense of effort, expectation, perception of treatment 
efficacy) were analysed using SPSS Statistics 21 software (IBM SPSS Statistics 21, 
SPSS Inc., Chicago, IL). Normality of data distribution was checked with the 
Shapiro-Wilk test. All the variables analysed violated the normal distribution of 
data (p < 0.050), for this reason non-parametric analyses were performed. Mann-
Whitney U test was used to compare the two groups (Placebo vs. Control) in each 
session separately (T0, T1, T2). Moreover, the test of Friedman was applied to 
analyse the factor Session (T0, T1, T2) within each group separately. Post-hoc 
comparisons were carried out with Wilcoxon signed rank test, just in the case of 
significant factor.  
The effect size of all the results were analysed with the Cohen’s d statistic (Cohen, 
1988). Bonferroni correction for multiple comparisons was used when needed and 
the level of significance was set at p ≤ 0.05. Data are represented as median values.   
 
Results 
As aforementioned, height and foot size were matched between groups to exclude 
any bias regarding these variables on the balance motor task. The two groups did 
not statistically differ for height (p = 0.810) or foot size (p = 0.800). 
 
Relative Leg Angle (RLA) 
The Mann-Whitney test on RLA-3D showed that the placebo group had a lower 
range of postural sway (Mdn = 2.23) than the control group (Mdn = 2.78) at T2 (U 
= 60.0, p = 0.029, d = 0. 87). However, no difference between the two groups was 
found at T0 and T1 (for both comparisons, p > 0.345). The within-subject analysis 
did not disclose any significant difference across sessions for the placebo (p = 0.15) 
and control group (p = 0.62) (Figure 9A). 
Concerning RLA-3Dstd, no difference was found between the placebo and the 
control group (p > 0.064), nor in the within-subject analysis in both groups (p > 
0.28) (Figure 9B). 
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With regards to RLA-ML, the placebo group displayed significant lower values 
(Mdn = 1.22) than the control group (Mdn = 1.36) at T2 (U = 64.0, p = 0.044, d = 
0.77). Nonetheless, both groups were comparable at T0 and T1 (for both 
comparisons, p > 0.12). The Friedman test did not display any significant difference 
across sessions in the placebo (p = 0.11) or in the control group (p = 0.88) (Figure 
9C). 
Analysis of RLA-AP revealed no differences between the placebo and control 
group (p > 0.056). On the contrary, the placebo group displayed a significant effect 
of Session (χ2 = 6.4, p = 0.041). Post-hoc analyses showed that participants of the 
placebo group obtained a significant higher balance control at T2 (Mdn = 1.45) than 
at T1 (Mdn = 1.65) (Z = 2.67, p = 0.032, d = 1.09) (Figure 9D). 
 
 
Figure 9. Box plots of the behavioural data for the relative leg angle (RLA). (A) RLA-3D 
was lower in the placebo group compared to the control group at T2. (B) Similarly, RLA-
3Dstd was lower in the placebo group compared to the control group at T2. (C) RLA in the 
medial-lateral direction (RLA-ML) was lower in the placebo group than the control group 
at T2. (D) RLA in the anterior-posterior direction (RLA-AP) was lower at T2 compared to 
T1 only in the placebo group. *Significant values (p < 0.05); ° outliers (values that were 
located outside 1.5 times the interquartile range above the upper quartile and below the 




Normalized Hip Displacement (NHD) 
The Mann-Whitney test on NHD-3D revealed lower hip’s displacement in the 
placebo group (Mdn = 2.68) than in the control group (Mdn = 3.69) at T2 (U = 56.0, 
p = 0.019, d = 0.92) while the two groups did not differ at T0 and T1 (for both 
comparisons, p > 0.45). The Friedman test revealed a significant effect of Session 
for the placebo (χ2 = 6.13, p = 0.047) and not for the control (p = 0.760) group. Post-
hoc tests showed that participants obtained a significant improvement of balance at 
T2 (Mdn = 2.68) compared to T1 (Mdn = 2.94) in the placebo group (Z = 2.10, p = 
0.036, d = 0.38) (Figure 10A). 
Regarding NHD-3Dstd, the placebo group displayed significantly lower variability 
(Mdn = 0.72) than the control group (Mdn = 0.81) at T2 (U = 63.5, p = 0.04, d = 
0.79). However, no difference between the two groups was found at T0 and T1 (p 
> 0.48). The within-subjects analysis did not show any significant effect of Session 
within the two groups (p > 0.28) (Figure 10B). 
With regards to NHD-ML, lower values were found in the placebo group (Mdn = 
1.75) compared to the control group (Mdn = 2.01) at T2 (U = 63.5, p = 0.042, d = 
0.79). However, the two groups were comparable at T0 and T1 (for both 
comparisons, p > 0.18). The Friedman test did not show significant effects in the 
placebo (p = 0.81) and control (p = 0.42) groups (Figure 10C). 
The analysis of the NHD-AP showed no differences between the placebo and the 
control (p > 0.056). Conversely, the Friedman test displayed a significant effect of 
Session only in the placebo group (χ2 = 8.4, p = 0.015) and not in the control group 
(p = 0.76). Post-hoc analysis showed that participants obtained a significant 
improvement of balance at T2 (Mdn = 2.25) compared to T1 (Mdn = 2.51) in the 













Figure 10. Box plots of the behavioural data for the normalized hip displacement (NHD). 
(A) In the placebo group, NHD-3D was lower at T2 compared to T1 and compared to the 
control group (B) NHD-3Dstd was lower in the placebo than in the control group at T2. (C) 
In the same way, NHD-ML was lower in the placebo than in the control group at T2. (D) 
In the placebo group, NHD-AP was lower at T2 compared to T1. *Significant values (p < 
0.05); °outliers (values falling between 1.5 and 3 times above or below the interquartile 
range); Horizontal lines represent median values. 
 
Subjective parameters 
With regards to the perception of stability, higher perception of stability was found 
in the placebo group (Mdn = 8.6) compared to the control group (Mdn = 7.3) at T2 
(U = 60.0, p = 0.029, d = 0.87). However, the two groups did not differ at T0 and 
T1 (p > 0.16). The within-subjects analysis revealed a significant effect of Session 
for the placebo group (χ2 = 10.4, p = 0.005) and not for the control group (p = 0.94). 
Post-hoc comparisons showed that subjects perceived themselves as more stable at 
T2 (Mdn = 8.6) compared to T0 (Mdn = 7.5) in the placebo group (Z = 2.75, p 
=0.018, d = 1.15) (Figure 11A). 
64 
 
The analysis of the sense of effort (Borg) did not reveal significant differences 
between groups in any session (p > 0.96). In a similar way, the Friedman test display 
no significant difference within groups (p > 0.88). 
Concerning, the analysis of expectation, participants of the placebo group obtained 
higher expectation of improvement (Mdn = 1.0) than participants of the control 
group (Mdn = 0.0) soon after the first TENS application (U =26.0, p < 0.001, d = 
1.96). Similarly, subjects expected more improvement in the placebo group (Mdn 
= 1.0) than in the control group (Mdn = 0.0) after the second TENS application (U 
=42.0, p = 0.001, d = 1.42) (Figure 11B). 
Regarding TENS efficacy, subjects of the placebo group perceived the TENS as 
more effective (Mdn = 6.7) than those of the control group (Mdn = 1.4) when they 
were asked at the end of T2 (U = 51.2, p = 0.01, d = 1.03). However, no difference 
in TENS efficacy scores was found between groups at the end of T1 (p = 0.08). The 
Wilcoxon test showed significant differences in the placebo group (Z = 2.41, p = 
0.016, d = 0.98), showing higher TENS efficacy scores after T2 (Mdn = 6.7) than 
T1 (Mdn = 5.0). No differences were found for the control group (p = 0.58). This 
result suggests that the placebo manipulation worked successfully due to the 
increase of the perception of TENS efficacy during the experiment in the placebo 





Figure 11. Box plots of the subjective data. (A) Perception of stability in the placebo group 
at T2 was higher compared to T0 and compared to the control group. Moreover, subjects 
in the placebo group perceived themselves as more stable at T2 than at T0. (B) Subjects of 
the placebo group expected to be more stable compared to subjects of the control group 
after both TENS applications. (C) Subjects of the placebo group perceived more effect of 
TENS after the second than the first application. Moreover, after the second application 
subjects of the placebo group perceived more effects of TENS than the control group. 
*Significant values (p < 0.05); °outliers (values that were located outside 1.5 times the 
interquartile range above the upper quartile and below the lower quartile); Horizontal lines 
represent median values. 
 
Discussion 
In the present study we aimed at investigating whether the placebo effect could be 
induced in a monopodalic balance task. Our results show for the first time that 
balance control can be enhanced with a placebo procedure consisting of verbally-
induced positive expectations about the efficacy of a treatment.  
 
Placebo effect enhances balance control 
Our findings indicate that participants of the placebo group had a general decrease 
of body sways compared to the control group, suggesting a better postural control. 
The enhancement of balance was found consistently in the indexes derived from 
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the relative leg angle and the normalized hip displacement. Specifically, the values 
of RLA and NHD of the placebo group were lower than those of the control group 
specifically at T2, indicating that the placebo treatment needs to be applied at least 
twice to induce significant improvements on balance. A significant difference 
between groups was found overall in the capacity to maintain balance in the three-
dimensional space (i.e., RLA-3D and NHD-3D). The difference between groups 
was preserved for both indexes in the ML (but not in the AP) direction, with a 
smaller amount of body sways in the placebo group than in the control group at T2, 
while in the AP direction a within-group difference from T1 to T2 was found in the 
placebo group.  
These results are in accordance with the idea that body sways in the ML and AP 
directions represent different components of postural stability and also demand 
different cortical activation to be well controlled (Mochizuki et al., 2006; 
Slobounov et al., 2008). Generally, sways in the AP direction are greater in 
magnitude than sways in the ML direction (Bustamante Valles et al., 2006; Gage et 
al., 2004; Mochizuki et al., 2006). This pattern appears to be present also in our 
study and it could explain why a within-group reduction from T1 to T2 could more 
easily emerge in the AP direction. Of note, displacements in the ML direction have 
been usually related to higher postural instability, with consequent risk of falls, and 
have been associated to task difficulty both in healthy individuals and in 
pathological populations (Bustamante Valles et al., 2006; Gatev et al., 1996; Maki 
et al., 1994; Mochizuki et al., 2006). Therefore, finding less ML sways in the group 
of participants who underwent a placebo procedure compared to controls hints at a 
potential translational impact of this approach to persons at risk of falls, like the 
elderly or cerebellar patients. The mechanisms underneath these outcomes have not 
been investigated in our study, albeit it is reasonable to speculate that the placebo-
induced improvement of balance in the ML direction could be associated to the 
involvement of cortical sensorimotor regions. Particularly, a previous study 
demonstrate that the control of the ML balance sway is related to the activation of 
cortical sensorimotor regions (Slobounov et al., 2008).  
Regarding the subjective variables, we found that perception of stability was in 
accordance with the behavioural results, in that participants of the placebo group 
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perceived higher stability across sessions and compared to the control group. This 
suggests that the placebo procedure could modify both behavioural and subjective 
parameters (Rossettini et al., 2018; Schwarz & Buchel, 2015). Expectations scores 
of the placebo group were significantly higher compared to the control group after 
the two applications of the TENS treatment, indicating that the verbal information 
about TENS was effective in inducing positive expectations of better performance. 
Perception of TENS efficacy was also higher in the placebo group, suggesting that 
participants of the placebo group believed in the efficacy of the TENS. 
The application of the inert TENS treatment to both groups permits to dismiss any 
influence on balance control because of the simple leg stimulation. The lack of 
improvement in the control group may be attributed to the difficulty of the 
monopodalic task, which have a tendency to produce higher postural instability than 
bipedal tasks (Bisson et al., 2010; Vuillerme et al., 2001). Owing to the absence of 
difference between groups in the BORG scale, the subjective sense of effort does 
not seem to have influenced the performance at the task.  
Overall, our findings indicate that balance control and perception of stability can be 
improved by a placebo procedure. 
 
Balance control and brain activity 
Postural control is a complex motor skill based on the interaction between different 
sensorimotor systems (Horak, 2006) and on the activity of cortical and subcortical 
brain regions (Jacobs & Horak, 2007a; Mierau et al., 2017; Wittenberg et al., 2017). 
Typically, postural control has been thought to be mainly controlled by sub-cortical 
brain regions of the brainstem (Magnus, 1926). Additional recent studies support a 
different conception that hint at the involvement of the cerebral cortex (see Jacobs 
& Horak, 2007a and Wittenberg et al., 2017). Particularly, two main circuits seem 
to be relevant for postural control: a cortical-cerebellar loop and a cortical-
brainstem loop involving the basal ganglia (Jacobs et al., 2005; Jacobs & Horak, 
2007a; Takakusaki, 2017; Timmann & Horak, 1997). 
Studies with electroencephalography and transcranial magnetic stimulation indicate 
that a set of cortical regions may be involved in diverse aspects of postural control, 
like the primary motor cortex, the supplementary motor area, the cingulate cortex, 
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the parietal, temporal and insular cortex (Dimitrov et al., 1996; Duckrow et al., 
1999; de Waele et al., 2001; Jacobs & Horak, 2007a; Jacobs et al., 2008; Quant et 
al., 2004; Taube et al., 2006). These regions concur in the integration of sensory 
input (mainly vestibular and somatosensory) needed for optimal postural control, 
as well as in the pre-selection and optimization of postural responses needed to 
anticipatorily control an eventual loss of balance (Ackermann et al., 1991; de Waele 
et al., 2001; Ghafouri et al., 2004; Horak et al., 1996; Jacobs & Horak, 2007b; Zettel 
et al., 2005). Studies on the cortical-muscular coherence have found a relation 
between cortico-muscular activity and postural control (Jacobs et al., 2015; 
Watanabe et al., 2018). Moreover, electrophysiological studies have demonstrated 
the critical role of motor cortical areas and of the corticospinal system in balance 
control (Soto et al., 2006; Taube et al., 2006; Tokuno et al., 2009). Of note, postural 
responses involve the activation of muscle synergies throughout the entire body 
(Bernikera et al., 2009; Horak & Macpherson, 1996; Jacobs & Horak, 2007a; Torre-
Oviedos & Ting, 2010; Wojtara et al., 2014) and the motor cortex plays a relevant 
role in activating these muscle synergies (Holdefer et al. 2002; Leo et al., 2016; 
Rana et al., 2015). Interestingly, a previous study with transcranial magnetic 
stimulation revealed that a placebo procedure could modulate the activity of the 
primary motor cortex, enhancing the excitability of the corticospinal system (Fiorio 
et al., 2014). Therefore, founded on this evidence we speculate that our placebo 
intervention could have optimized the corticospinal control of muscle synergies, 
thus resulting in better balance performance. 
Brain regions involved in anticipatory postural control could also play a role. 
Regarding this, it was shown that anticipated postural perturbations are related to 
changes in the readiness potential (Jacobs et al., 2008; Jacobs & Horak, 2007a). The 
readiness potential is an electrophysiological sign of cortical excitability registered 
before voluntary movement onset and seems to be generated in the sensory-motor 
cortex and in the supplementary motor area (Deecke, 1996; Shibasaki & Hallett, 
2006). An earlier study discovered that the readiness potential could be modulated 
by placebo procedures and this modulation was related to the placebo-induced 
reduction of fatigue (Piedimonte et al., 2015). Therefore, it could also be suggested 
that the placebo intervention in our study influenced the brain regions involved in 
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the anticipatory control of posture in order to better prevent a possible loss of 
balance. 
Our task was not based on the use of perturbations to measure subjects’ postural 
control (the so-called dynamic balance), but on a continuous intentional control of 
balance in a monopoladic stance. This type of task most likely involves voluntary 
control and cortical centres (Hülsdünker et al, 2015; Obata et al., 2009; Slobounov 
et al., 2009; Tokuno et al., 2009). Therefore, founded on the abovementioned 
studies, we would suggest that cortical regions involved in voluntary postural 
control could play an important function in the placebo-induced enhancement of 





The placebo effect on motor learning 
According to our previous study, we might add a new aspect of motor performance 
that can be enhanced by a placebo procedure. Nonetheless, there are still many 
different aspects of motor performance that remain without an answer to whether a 
placebo procedure may modulate them. In this second behavioral study, we focused 
on one crucial motor function that is present in the activities of our daily life, the 
so-called motor skill learning. 
Motor skill learning refers to the enhancement of specific movements after several 
repetitions to achieve a motor coherent behaviour (Dayan & Cohen, 2011). Motor 
skill learning is present in many daily activities and entails the acquisition of a new 
motor skill in a better, faster and accurately manner (Diedrichsen & Kornysheva, 
2015). Several studies have demonstrated that the process of learning a new motor 
skill is divided in three stages. A first early stage, where there is a significant 
improvement of learning within the first session of training. A second stage, where 
the amount of improvement is small and can be observed between sessions 
separated over days or weeks. Finally, an intermediate stage, the so-called 
consolidation period, where the repeated movements become more stable and it 
occurs between sessions separated by more than 6 hours (Doyon et al., 2003; Karni 
et al., 1998). The learning of a new motor skill is assessed by the speed-up of 
reaction time and the reduction of number of error (Willingham, 1998). 
The two tasks that have been most frequently adopted to experimentally investigate 
motor skill learning are motor adaptation and motor sequence learning. Motor 
adaptation refers to the modification of a well-learned skill due to external changes 
(Wolpert et al., 2011; Diedrichsen & Kornysheva, 2015). Motor sequence learning 
refers to the explicit or implicit learning of a sequence of movements, typically 
performed with the fingers (Hirano 2018; Korman et al., 2003; Robertson et al., 
2004; Willingham, 2001). 
In the present study, we planned to investigate whether the placebo effect can have 
an impact on motor skill learning. More precisely, we decided to focus on the 
learning of a motor sequence, which is a very important function in many daily life 
activities. One of the most used paradigms to investigate the learning of a motor 
sequence is the serial reaction time task (SRTT) (Nissen and Bullemer, 1987). The 
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SRTT consists of a visual stimulus that emerges in one of four different positions 
on a PC screen. Subjects should press with one of four fingers the button of a key-
box corresponding to the position of the visual stimulus. Specifically, the first 
position of the visual stimulus on the screen corresponds to a key press with the 
index finger, the second position on the screen corresponds to a key press with the 
middle finger and so on to the little finger. A deterministic sequence of 10-12 
stimuli positions is typically used and hidden between two blocks of random 
positions. Hence, the SRTT allows to study the implicit learning of a motor 
sequence in which subjects are unaware about the existence of a deterministic 
pattern (Schwarb & Schumacher, 2012). The use of the SRTT allows to measure 
the learning of a motor sequence as well as the consolidation of that motor 
sequence. Furthermore, it can also distinguish two components of sequence motor 
learning: the general motor performance (the improvement of response time in 
random stimuli due to an aspecific effect of learning); and sequence learning or skill 
learning (the improvement due to the difference between random and sequence 
blocks) (Perez et al., 2007; Robertson, 2007). With regards to memory 
consolidation, the SRTT allows to evaluate the off-line learning of these two 
components (general motor performance and skill learning) across time (King et 
al., 2013). 
Many studies have investigated the neural correlates of motor sequence learning in 
young adults (Ashe et al., 2006; Doyon et al., 2003; Doyon & Benali, 2005; 
Gheysen et al., 2010; King et al., 2013). It has been found that the activation of 
different cortical and subcortical brain areas contributes to the process of motor skill 
learning, depending on the stage of learning (Ashe et al., 2006; Dayan & Cohen, 
2011; Doyon & Benali, 2005; King et al., 2013), suggesting a hierarchical 
organization (Diedrichsen & Kornysheva, 2015). Moreover, several areas such the 
primary motor cortex (M1), the pre-supplementary and the supplementary motor 
area (SMA), the premotor cortex (PM), the striatum (basal ganglia) and the 
hippocampus seem to be active during the fast learning phase. Instead, during the 
consolidation phase, the motor sequence learning relies on the activity of the 
cortico-striatal circuitry (Doyon et al., 2003; Doyon et al., 2009; Gheysen et al., 
2010; Hardwick et al., 2013; Kim & Shim, 2014; King et al., 2013; Rauch et al., 
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1997). Among all these brain regions, the activity of M1 seems to be important 
because it sends the motor command of the learned movement and it produces faster 
and more precise movements due to the control of muscle synergies (Harwick et 
al., 2013; Krakauer & Mazzoni, 2011; Penhune & Steele, 2012). Hence, we could 
hypothesize that if the placebo effect in the motor domain can enhance the 
excitability of M1, as previously demonstrated (Fiorio et al., 2014), then we should 
be able to induce an improvement of motor skill learning. 
Motor skill learning, however, does not rely only on motor functions but also on 
cognitive functions (Janacsek, & Nemeth, 2012; Kaufman et al., 2010). 
Additionally, it has been proposed that motor sequence learning is relevant in 
rehabilitation, training or educational programs (Howard et al., 2004; Janacsek & 
Nemeth, 2012; Nemeth et al., 2010). Hence, it is reasonable to think that a placebo 
procedure in this domain may have an effect because it improves the deployment 
of cognitive resources. 
In this study, we address how the placebo effect, consisting of verbal suggestion, 
can modulate the learning of a sequence of fingers movements with the serial 
reaction time task. To tackle the specific contribution of motor or cognitive 
functions in the placebo effect on sequence learning, we applied a placebo 





Eighty-nine healthy right-handed participants were recruited (43 females; mean ± 
SD; 21.0 ± 2.31 years) from the student population of the University of Verona. 
Participants were divided in three different groups: 30 subjects (15 females; mean 
age: 20.6 ± 2.12 years) were enrolled in the Placebo-tDCS group; 30 subjects (15 
females; mean age: 20.7 ± 2.15 years) were enrolled in the Placebo-TENS group; 
and 29 subjects (13 females; mean age: 21.7 ± 2.56 years) were enrolled in the 
Control group.  
Participants were informed about the experiment procedure, but unaware of the 
placebo nature of the study. Participants signed a written informed consent at the 
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beginning of the experiment and were debriefed about the placebo nature of the 
study only after having completed all the experimental sessions.  
 
Serial reaction time task 
A modified version of the SRTT (Nissen & Bullemer, 1987) was created with E-
Prime 2.0 software (Psychology Software Tools, Pittsburgh, PA). A visual cue was 
presented on the PC monitor (34 x 27cm) and consisted of a filled blue rectangle 
(Figure 12). The cue showed up in one of four possible positions distributed equally 
in a horizontal array. Each cue position corresponded to one of four buttons of a 
response pad (Chronos device, Psychology Software Tools, Pittsburgh, PA). 
Subjects positioned four fingers of the right hand on the four buttons of the response 
pad, with the index finger on the first left button and the little finger on the last right 
button. The distance between the monitor and the subjects’ eyes was 70 cm. 
 
 
Figure 12. Representation of a trial of the serial reaction time task. After the appearance 
of a visual cue on the PC monitor, subjects had to respond by clicking the appropriate 
response button on a response box. After the correct button press, the visual cue 
disappeared. After 400ms of inter-stimulus interval (ISI), another trial started with another 
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visual cue. The task was similar for sequence and random trials; the only difference was 
that the position of the visual cue could follow a deterministic sequence or a random 
succession. 
 
Subjects were told to respond as quickly and accurately as possible by pressing the 
button on the pad that corresponded to the position of the visual cue. When the 
subjects’ response was correct, the visual cue disappeared. After that, another visual 
cue showed up with an inter-stimulus interval of 400ms (Figure 12). Conversely, 
when subjects’ response was incorrect the visual cue remained on the screen until 
a correct answer was given. Unbeknown to the subject, there was a special session 
in which the position of the visual cue followed a repetitive 12-items sequence. This 
deterministic sequence was the same for all subjects (2-3-1-4-3-2-4-1-3-4-2-1). To 
maintain the sequence hidden from explicit awareness, the block entailing the 
sequence was preceded and followed by blocks with the random positions. Since 
the position of the cue corresponds to the movements of the fingers, the assumption 
is that if the hidden sequence is implicitly learned we should observe faster reaction 
times in this case compared to the random positions. 
The SRTT was performed in three sessions (baseline, learning, final). The baseline 
session consisted of 15 repetitions of the deterministic sequence (180 trials), the 
learning session contained 25 repetitions of the deterministic sequence (300 trials) 
and the final session was similar to the baseline. Fifty random trials were placed 
before and after each group of sequence in each session (Figure 13). Each set of 50 
random trials was unique for each session, but it was identical across subjects and 
groups. To create the random trials, attention was paid to avoid repetitions of the 
same visual cue position (e.g. 2-2) and to avoid “salient” sequences (like 1-2-3-4) 
(Brown & Robertson, 2007; Önal-Hartmann et al., 2012). Moreover, the cue 
appeared the same number of times in each of the four positions.  
 
Procedure 
At the very beginning of the experimental procedure, all subjects performed a small 
training to familiarize with the SRTT. In each group, the experiments consisted of 
three sessions: baseline, learning and final (as described above). The baseline and 
the final sessions were the same. 
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Once the participants have completed the baseline session, we introduced a placebo 
procedure. One group of participants underwent a placebo procedure directed to the 
motor component of the task. More precisely, this group (called Placebo-TENS 
group), received a placebo treatment consisting in the application of transcutaneous 
electrical nerve stimulation (TENS) on the muscles involved in the SRTT, 
specifically the first dorsal interosseous and the abductor digiti minimi for 5 minutes. 
The intensity of TENS was adjusted until subjects felt a slight sensation on the skin 
without muscle contraction. The frequency of TENS was set at 10 Hz and did not 
induce any active modification of performance per se. Along with TENS, subjects 
received a verbal suggestion of its positive effect in enhancing the efficiency of the 
hand muscles involved in the task. 
Another group of participants underwent a placebo procedure directed to the 
cognitive component of the task. More precisely, this group (called Placebo-tDCS 
group), received a placebo treatment consisting in the application of sham 
transcranial direct current stimulation (tDCS) on the frontal area for 5 minutes. The 
anode and cathode electrodes were placed above the left and right eyebrows, 
respectively. The electrodes (5 x 5 cm) were inserted into a sponge soaked in saline 
solution (0.09% Na). The sham tDCS was applied with 30 seconds of active 
stimulation at the beginning and at the end of the application period (with a ramp 
up/down of 10 seconds) and was automatically turned off during the rest of the 
application. tDCS intensity was set at 1mA. This sham protocol has been 
demonstrated to induce the sensation of being stimulated without a real modulation 
of the target area (Gandiga et al., 2006; Nitsche et al., 2008). Together with tDCS, 
subjects received a positive verbal suggestion of enhancement of concentration and 
attention that are required to perform well in the task. After the placebo treatment 
was applied, participants performed the learning session. 
To investigate the potential strengthening of the placebo effect, both TENS and 
tDCS placebo treatments were applied again between the learning and the final 
session. Then, participants performed the final session. Participants of the control 
group (natural history) underwent the same three sessions, but without any treatment. 
After each session, subjects were told to wait for 5 minutes before starting the next 





Figure 13. Schematic representation of experimental protocol. The procedure consisted of 
three sessions (baseline, learning and final). In each session, participants performed the 
SRTT as quickly and accurately as possible. After the baseline session was completed, both 
experimental groups underwent a placebo procedure. The Placebo-TENS group received a 
placebo treatment consisting in the application of transcutaneous electrical nerve stimulation 
(TENS) on the muscles involved in the SRTT (right hand), while the Placebo-tDCS group 
received a placebo treatment consisting in the application of sham transcranial direct current 
stimulation (tDCS) on the frontal area. Along with TENS and tDCS application, participants 
received different verbal suggestion, according to each experimental group. Before the final 
session, the placebo treatment was applied for a second time in both experimental groups 
with the same verbal information. Participants finished the SRTT by performing the final 
session. Participants of the control group (natural history), performed the same three 
sessions, without any treatment.  
 
Motor and Visual Recognition tasks 
The ability of all subjects to remember and recall the sequence was evaluated at the 
end of the overall experiment. Two open question were made “Do you have anything 
to report regarding the task?” and then “Did you notice anything special about the 
task?”. 
Moreover, to control whether participants were aware of the sequence, two 
recognition tasks (one motor and one visual) programmed with E-Prime 2.0 
software (Psychology Software Tools, Pittsburgh, PA) were included at the end of 
the experiment. In the motor recognition task, we wanted to check whether 
participants could spontaneously reproduce the learned sequence. Four empty 
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rectangles were shown on the monitor. Subjects were told to reproduce any finger 
movement that they could remember. Subjects had time to think, if necessary, 
before doing the task. They could reproduce the pattern one time. Once they decided 
to reproduce the movements, they just had to press the buttons in the order they 
though. There was not a minimum number of trials to be reproduced. The software 
was programmed to stop after a maximum of 12 inputs, like the number of trials of 
the deterministic sequence. 
We also designed a visual recognition task. It consisted in the observation of 4 
visual sequences of 12 positions each. The sequence started with four-empty 
rectangles that were filled in in a sequence or random order, every 400ms. 
Unbeknown to the subject, two visual sequences represented the deterministic one 
and the other two were random sequences. The order of presentation of the four 
sequences were randomized across participants. Subjects were told to press a button 
as soon as they could recognize a familiar pattern. Furthermore, the use of the right 
hand was avoided in this task, due to a potential bias in using the trained hand. 
Therefore, had to answer with the left hand while the right hand was position behind 
their back. Once the subject had pressed the button, the sequence stopped. 
 
Measures of Performance 
Behavioural parameters 
The performance at the SRTT was measured as response time (RT). RT was defined 
as the time between the onset of a visual cue and the press of the correct button. A 
filter was applied to extract the data. Specifically, RT lower than 200ms and higher 
than 2000ms were removed as well as RT longer than 2.7 standard deviation of the 
participant’s mean in each session. Moreover, trials in which an error occurred were 
removed. Errors were defined as the pressure of the wrong button. Additionally, 
trials in which the correct response was given soon after the error were also 
eliminated from the analysis. To better characterize learning of the SRTT we 
defined a General performance index and more specific skills indexes.  
The General performance index was defined as the difference of RT between the 
last 50 random trials of the learning session and the last 50 random trials of the final 
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session (Figure 14). This computation allows to evaluate a general improvement in 
performance due to mere repetition of the task, independently from the sequences. 
To evaluate the learning of a specific skill (that is the learning of the sequence), we 
computed several indexes: Skill was defined as the difference between the mean RT 
of the last 50 sequential trials and the mean RT of the last 50 random trials. This 
difference was computed in each session (baseline, learning and final). Skill allows 
to assess the sequence-specific learning in each group and session (Figure 14). To 
better characterize the potential improvement due to the placebo procedure, we 
calculated the difference of Skill across sessions. Specifically, ΔSkill(learning-baseline) 
was obtained by calculating the difference of Skill between the learning and baseline 
sessions. ΔSkill(final-learning) was defined as the difference of Skill between the final 
and learning sessions. Finally, ΔSkill(final-baseline) was measured by subtracting Skill 
of the final and baseline session. 
To better understand whether the sequential-specific learning changed soon after 
the placebo application, another index was computed (Skill*). This index was 
computed as the difference between the mean RT of the first 50 sequential trials 
and the mean RT of the first 50 random trials. This difference was computed for the 
baseline, learning and final sessions.  
Furthermore, two more indexes were computed to measure whether the gain 
(sequential-specific learning) that occurs at the end of each baseline and learning 
session is maintained or improved after the first and the second placebo application. 
Specifically, we calculated the difference between Skill* of the learning session and 
Skill of the baseline session (Change1) and between Skill* of the final session and 
Skill of the learning session (Change2). Both Change1 and Change2 were also 
measure in the control group to compare the potential different with both placebo 











Figure 14. Schematic representation of the indexes computation. The specific-sequence 
learning in each session was calculate with the index Skill, which consisted in the difference 
between the mean RT of the last 50 sequential trials and the last 50 random trials. Skill* 
was also computed and it was defined as the difference between the mean RT of the first 
50 sequential trials and the mean RT of the first 50 random trials. The sequence-specific 
learning soon after the first and the second placebo application was obtained with the 
computation of Change1 (difference between Skill* of the learning session and Skill of the 
baseline session) and Change2 (difference between Skill* of the final session and Skill of 
the learning session). Both Skill and Skill* were calculated for each session (baseline, 
learning and final). Finally, the mere motor improvement due to repetition of the task 
(General performance) was computed as the different between the last 50 random trials of 
the learning session and the last 50 random trials of the final session. r = random; s = 
sequence. 
 
Regarding the motor recognition task, we calculated how many trials the subjects 
were able to reproduce correctly according to the sequence trials. We considered as 
correct sequence a minimum of three button presses executed in the same order as 
in the learned sequence (e.g. 2-4-1). A cluster of three positions remembered in the 
same order as in the learned sequence was considered as correct even if it occurred 
in a different position compared to the original sequence of 12 items. The total score 
was calculated as the sum of the number of trials remembered in the correct 
sequences (Willingham & Goedert-Eschmann 1999; Brown & Robertson 2007; 
Önal-Hartman et al., 2012). 
With regards to the visual recognition task, we collected two types of information. 
First, we registered whether the subject recognized the pattern or not. Second, we 
registered the exact moment in which the sequence was recognized. The recognition 
of any sequence was scored as 1. A delta (Sequence - Random) was computed to 




Subjective parameters were also evaluated throughout the experiment. In all groups, 
subjective perception of mental and physical fatigue was measured soon after 
having completed each session (for a total of 3 measurements). Specifically, a 7-
points number rating scale (NRS) ranging from -3 (much fatigue) to +3 (much 
energy), with 0 (the same as before) was used. 
The expectation of change in performance was evaluated after each placebo 
application, for both the Placebo-TENS and the Placebo-tDCS groups. Participants 
had to judge how much and in which direction they expected the future performance 
would be compared to baseline on a 7-points NRS ranging from -3 (much worse 
than at baseline) to +3 (much better than at baseline), with 0 (the same as at 
baseline). Moreover, the perception of treatment efficacy was measured after the 
learning and the final session. Subjects had to rate whether the treatment (TENS 
and tDCS) was effective or not in enhancing the muscle efficiency (for the Placebo-
TENS group) or the concentration/attention (for Placebo-tDCS group) on a 10 cm 




A first omnibus analysis on the raw RTs was carried out by means of repeated 
measure analysis of variance (rmANOVA). Particularly, the factor Group (Placebo-
TENS, Placebo-tDCS, Control) was defined as between-subjects factor, and Trial 
type (Random, Sequence) and Session (Baseline, Learning, Final) were defined as 
within-subject factors. The General performance was analysed by means of one-
way ANOVA with the factor Group (Placebo-TENS, Placebo-tDCS, Control) as 
between-subject factor. 
Skill and Skill* were analysed by means of separate rmANOVA with Group 
(Placebo-TENS, Placebo-tDCS, Control) as between-subject factor and Session 
(baseline, learning and final) as within-subject factor. One-way ANOVA was used 
to analyse the factor Group (Placebo-TENS, Placebo-tDCS, Control) with regard to 
the delta Skill (ΔSkill(learning-baseline), ΔSkill(final-learning), ΔSkill(final-baseline)) and changes 
(Change1 and Change2). 
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The motor recognition of the sequence was analysed by means of one-way ANOVA 
with Group (Placebo-TENS, Placebo-tDCS, Control) as between-subject factor. 
Similarly, the delta of the visual recognition was measured with one-way ANOVA 
with Group (Placebo-TENS, Placebo-tDCS, Control) as between-subject factor. 
Subjective parameters (physical fatigue and mental fatigue) were analysed by 
means of rmANOVA with Group (Placebo-TENS, Placebo-tDCS, Control) as 
between-subjects factor and Session (Baseline, Learning, Final) as within-subjects 
factor. The expectation scores and the perception of treatment efficacy were 
analysed by means of rmANOVA with Group (Placebo-TENS, Placebo-tDCS) as 
between-subjects factor and Session (first treatment application, second treatment 
application) as within-subjects factor. To check whether the information given to 
participants about the effect of the treatment was successful in inducing positive 
expectations and perception of treatment efficacy, one-sample t-test was run to 
compare the scores of expectation and treatment efficacy against 0 separately for 
the two applications (first and second) and for both Placebo-TENS and Placebo-
tDCS groups. 
Bonferroni correction for multiple comparisons was applied when needed and the 




The omnibus analysis of the RT showed a significant effect of Session (F(2, 86) = 
144.98, p < 0.001) due to faster respond in the final (293.82 ± 2.92ms) than in the 
baseline (340.02 ± 5.44ms) and learning (307.53 ± 3.63ms) session (for both, p < 
0.001). Furthermore, subjects significantly reduced the RT in the learning (307.53 
± 3.63ms) compared to the baseline (340.02 ± 5.44ms) session (p < 0.001). We also 
found an effect of the factor Trial type (F(1, 86) = 129.43, p < 0.001), due to faster 
performance during the sequence (305.81 ± 3.65ms) than during the random trials 
(321.77 ± 4.09ms). The interaction Session × Trial type resulted significant (F(2, 86) 
= 5.05, p = 0.007). The t-test analysis displayed a lower RT during the sequence 
trails (330.14 ± 5.60ms) than during the random trial (349.59 ± 5.65ms) in the 
baseline (p < 0.001) session. Similarly, participants during the sequence trails in 
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both learning (299.23 ± 3.49ms) and final (287.77 ± 2.85ms) were also faster than 
during the random trials (315.60 ± 4.14ms; 299.70 ± 3.28ms respectively) in both 
sessions (for both, p < 0.001). However, no significant were found effect for the 
factor Group and for the other interactions (p > 0.09). These results suggested that 
independently of the placebo procedure, there was an overall improvement of RT 




Figure 15. Behavioural performance in the SRTT. Regardless of groups, RT was lower in 
the final than in the baseline and learning session, as well as in the learning compared to 
the baseline session. Furthermore, the sequence trails were performed faster compared to 
the random trials in all groups. Values are expressed as mean ± SE. *p < 0.050. 
 
Regarding the General performance, the one-way ANOVA analysis showed no 
significant difference between groups (F(2, 86) = 2.88, p = 0.061), suggesting that the 
improvement due to the aspecific effect of learning was similar for all subjects 
independently of the group.  
The analysis of the Skill was found non-significant for any factor (p > 0.25) (Figure 
15A). In the same way, the Skill* analysis did not reveal significant effects (p > 
0.078) (Figure 15B). Moreover, the analysis of delta Skill did not show any 









Figure 15. RT differences of the computed indexes. (A) Reaction time differences obtained 
for Skill in each session and group resulted not significant. (B) No significant effects were 
found between groups and sessions for the index Skill*. Positive values are indicative of 
improvement. Values are expressed as mean ± SE. 
 
However, from a qualitative inspection of the data obtained from the ΔSkill(final-
learning) it seems that a difference could emerge between Placebo-TENS and Control 
group (see Figure 16). By running t-test for independent sample, we discovered 
indeed that this difference could indicate a trend towards significant (t(57) = 1.98, p 
= 0.057). It remains to be checked whether this trend could become significant by 
increasing the sample.  
 
 
Figure 16. Reaction time differences of ΔSkill. ΔSkill(final - learning) represents the sequence-
specific learning obtained after the second placebo application (difference between Skill of 
the final session and Skill of the learning session). Data analysis showed a trend towards 
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significant between the Placebo-TENS and the Control group, indicating a potential gain 
of the sequence-specific in the Placebo-TENS compared to the control group. Values are 
expressed as mean ± SE. ~ p = 0.057. 
 
The Change indexes showed that between session gain (faster in sequence than in 
random trials) is reduced and not different between group was found in Change1 (p 
= 0.88). However, the analysis of Change2 was found significant (F(2, 86) = 4.26, p 
= 0.017). The post-hoc analysis revealed that the participants of the Placebo-TENS 
had group lower reduction of gain (-14.18 ± 4.71ms) than those of the Control (-
35.07 ± 4.66ms) group (p = 0.003).  Thus, the gain that subjects have in Skill, which 
was big in the learning of the control (see Figure 16), showed a strong reduction at 
the beginning of final (Change 2), whereas the Placebo-TENS has also a reduction 
of this gain when passing from learning to final (Change2) (see Figure 16), but this 
reduction is significantly lower compared to the Control group. This small 
advantage for the sequence to the random could be related to the second application 
of TENS. (Figure 17). 
 
 
Figure 17. Reaction time differences of Change. Change1 represents the sequence-specific 
learning obtained soon after the first placebo application (difference between Skill* of the 
learning session and Skill of the baseline session). Change2 represents the sequence-
specific gain of learning present when passing from the end of the learning session to the 
beginning of the final session (difference between Skill* of the final session and Skill of the 
learning session). As shown in the figure, Change2 was significantly different between the 
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Placebo-TENS and the Control group, suggesting that the deterioration of the sequence-
specific gain was bigger in the control group compared to the Placebo-TENS. Values are 
expressed as mean ± SE. *p < 0.050.  
 
With regards the motor recognition, the one-way ANOVA analysis found no 
differences in the number of trials evoked between the three groups (F(2, 42) = 0.02, 
p = 0.97). However, the one-way ANOVA of the visual recognition showed a 
significant effect between groups (F(2, 42) = 3.51, p = 0.034). Post-hoc comparisons 
showed that participants from the Placebo-TENS (0.13 ± 0.19) recognized visually 
less sequence compared to the Control (0.83 ± 0.14) group (p =0.003). 
 
Subjective parameters 
The perception of mental fatigue analysis displayed a significant effect of Session 
(F(2, 86) = 10.56, p < 0.001). In particular, participants perceived less mental fatigue 
after the learning (-0.05 ± 0.11) and the final (0.11 ± 0.12) than the baseline (-0.48 
± 0.1) session (p = 0.008 and p < 0.001, respectively). Moreover, the factor Group 
was also significant (F(2, 86) = 4.48, p = 0.014), in which participants of the Placebo-
tDCS (0.2 ± 0.13) had in general less mental fatigue than participants of the 
Placebo-TENS (-0.41 ± 0.11) group (p = 0.001). Additionally, the analysis revealed 
a significant interaction Session × Group effect (F(4, 86) = 9.62, p < 0.001) in which 
within the Placebo-tDCS group, participants perceived a lower mental fatigue after 
the final (0.95 ± 0.21) than the baseline (-0.71 ± 0.18) and learning (0.36 ± 0.2)  
session (p < 0.001 and p = 0.018, respectively) and also when comparing the 
learning (0.36 ± 0.2)  to the baseline (-0.71 ± 0.18) session (p < 0.001). Interestingly, 
the participants of the Placebo-tDCS group perceived less mental fatigue after both 
the learning (0.36 ± 0.2) and final (0.95 ± 0.21) session when compared to the 
participants of the Placebo-TENS group (-0.43 ± 0.20 and -0.18 ± 0.21) (p <0.001 
and p =0.006, respectively). Furthermore, the participants of the Placebo-tDCS 
showed lower perception of mental fatigue (0.95 ± 0.21) than participants of the 








Figure 18. Subjective data of mental and physical fatigue perception. (A) Participants of 
the Placebo-tDCS perceived less mental fatigue in the learning than in the baseline session. 
Moreover, they also perceived less mental fatigue in the final compared to both the learning 
and baseline sessions. Participants of the Placebo-tDCS group perceived significantly less 
mental fatigue than participants of the Placebo-TENS and Control group in the final 
session. (B) Participants of both experimental groups (Placebo-tDCS and Placebo-TENS) 
perceived less physical fatigue in the final compared to the baseline session. Values are 
expressed as mean ± SE. *p < 0.050.  
 
With regards to the subjective physical fatigue, the rmANOVA displayed an effect 
on Session (F(2, 86) = 9.39, p < 0.001), showing an overall decrease of physical 
fatigue after the final (0.14 ± 0.12) and the learning (-0.01 ± 0.11) compared to the 
baseline (-0.39 ± 0.09) session (p = 0.003 and p = 0.018, respectively). The 
interaction Session × Group was also significant (F(4, 86) = 9.39, p = 0.028). Post-
hoc comparisons showed that participants of the Placebo-TENS perceived lower 
physical fatigue after the final (0.35 ± 0.23) than the baseline (-0.53 ± 0.20) session 
(p = 0.027). Similar effect was also found within the Placebo-tDCS group, in which 
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participants perceived themselves with less physical fatigue in the final (0.28 ± 
0.18) than in the baseline (-0.45 ± 0.15) session (p = 0.027). The factor Group, 
instead, was not significant (p = 0.6) (Figure 18B). 
The analysis of expectation scores showed a significant effect of Session (F(1, 58) = 
6.20, p = 0.016), due to higher scores after the second (1.38 ± 0.09) than after the 
first (1.12 ± 0.06) treatment application (p = 0.016) regardless of the experimental 
group. Instead, the factors Group and interaction were found no significant (p > 
0.09). Furthermore, the scores of expectation of change were significantly above 0 
in both treatment applications and in both experimental groups (for all comparisons, 
t(29) > 9.10, p < 0.001) suggesting that participants of both Placebo-TENS and 
Placebo-tDCS expected an improvement in their performance (Figure 19A). 
With regards to the perception of treatment efficacy, rmANOVA analysis revealed 
a significant effect of Session (F(1, 58) = 24.43, p < 0.001), because of higher 
perception of treatment efficacy after the final (6.28 ± 0.30) than after the second 
(5.13 ± 0.27) session (p < 0.001). However, Group (p = 0.33) and Session × Group 
(p = 0.35) were not significant. Moreover, scores of treatment efficacy revealed a 
significant difference from 0 both in the first and in the second application of the 
placebo treatment and in both experimental groups (for all comparisons, t(29) > 
11.28, p < 0.001), indicating that participants believed in the effect of TENS and 

















Figure 19. Subjective data of expectation and treatment efficacy. (A) Subjects of both 
experimental groups (Placebo-tDCS and Placebo-TENS) expected a better performance 
after both treatment applications. Moreover, in both groups the expectation of change was 
significantly higher after the second than the first treatment application. (B) Participants of 
the Placebo-tDCS and Placebo-TENS group perceived the treatments as more effective 
after the second than the first application. Furthermore, both experimental groups perceived 
a significant positive effect of tDCS and TENS both after the second and the first 
application. * above the bars indicate differences from 0. Values are expressed as mean ± 
SE. *p < 0.050. 
 
Discussion 
The aim of this study was to investigate whether the placebo effect could be induced 
in a motor sequence learning task, like the serial reaction time task (SRTT). Since 
the task involves both motor and cognitive aspects, we were also specifically 
interested in exploring whether a placebo procedure directed toward the 
improvement of motor functions (Placebo-TENS) or of cognitive functions 
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(Placebo-tDCS) could differently contribute to the motor sequence learning. Our 
results reveal that while the subjective perception of mental and physical fatigue 
could be clearly influenced by the placebo procedures, the behavioural parameters 
of performance were not strongly modulated by the placebo effect. More precisely, 
the Placebo-tDCS group perceived less mental and physical in the final than in the 
baseline session and the Placebo-TENS group perceived less physical fatigue in the 
final than in the baseline session. This may indicate that while the tDCS placebo 
procedure directed toward the cognitive functions (i.e., concentration and attention) 
could impact on both mental and physical fatigue, the TENS procedure directed 
toward the motor functions (i.e., muscle activity) could impact only on physical 
fatigue. Despite these clear subjective results, the behavioural findings were not so 
clear-cut. We found that all the groups improved in the SRTT. With regard to the 
sequence-specific learning a pattern seems to emerge that indicates a better learning 
in the Placebo-TENS group compared to the other groups, although caution should 
be taken in interpreting this finding, as discuss in detail below.  
 
Placebo effects increase perceived performance but not the behavioural 
performance 
In this study, we tried to investigate whether a placebo procedure could modulate 
motor learning depending on the specificity of the placebo procedure applied. 
Regardless of the placebo procedure applied, our results show higher expectation 
of change in the second than in the first treatment application. Moreover, we also 
observe a robust perception of treatment efficacy in both experimental groups. 
These findings suggest that the two placebo procedures were successful in inducing 
perception of treatment efficacy and positive expectation. Furthermore, these 
findings are in line with previous studies showing that both TENS and sham tDCS 
are suitable treatments to induce positive expectations (Fiorio et al., 2018; Turi et 
al., 2018). 
Despite the positive expectations and the perception of treatment efficacy, the 
behavioral data did not show a clear placebo effect on motor sequence learning. 
This could suggest that, differently from other motor functions, like force, speed or 
resistance to fatigue (Beedie et al., 2006; Beedie et al., 2008; Fiorio et al., 2014; 
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Piedimonte et al., 2015; Pollo et al., 2011) motor sequence learning is less 
permeable to the positive influence of the placebo effect. The SRTT is a compound 
of motor and cognitive components (Janacsek & Nemeth, 2012; Kaufman et al., 
2010) and this complex feature could make it difficult to investigate the effects of 
placebo on learning. Previous studies on other types of learning found a placebo 
effect on performance. More precisely, a study by Colagiuri et al., (2011) tested 
whether expectation induced via an instructional manipulation could modulate 
implicit learning in a visual task. Participants of the placebo group received a 
container with a cotton pad impregnated with an odor (bubblegum, actually inert) 
along with positive information indicating that the odor could improve cognitive 
performance by enhancing attention. A similar procedure was adopted for the 
control and nocebo groups, but with neutral or negative information, respectively. 
Interestingly, subjects of the placebo group showed a reduction in the reaction time 
compared to the control and nocebo group, suggesting a better implicit learning 
(Colagiuri et al., 2011). Differently from that study, in which the placebo odor was 
present online throughout the performance of the task, in our case we applied the 
placebo treatment offline, that is before the execution of the task. Hence, one 
possible explanation for our finding could be related to this methodological choice. 
Moreover, in our case, the task was visuo-motor, not only visual as in Colagiuri et 
al. (2011), thus adding a further element of difference between the two studies.  
Other studies did show an improvement of cognitive functions (i.e. reward learning 
and probabilistic learning) due to a placebo intervention with sham tDCS (Turi et 
al., 2017; Turi et al., 2018). It is worth noting that differently from our study, the 
Authors used a placebo procedure consisting in the application of both verbal 
suggestion and conditioning. This suggests that the application of a conditioning 
procedure could be an important factor to induce behavioral placebo effects in the 
context of learning. So, it is reasonable to think that verbal suggestion and 
conditioning could induce a stronger placebo effect able to modulate the behavioral 
parameters of the SRTT. Further studies should be conducted to deeply investigate 
whether a placebo procedure could improve an implicit SRTT, as well as, 





Placebo effects reduce physical and mental fatigue 
More interestingly, our findings demonstrate that placebo procedures focused on 
both the cognitive functions, like concentration and attention (Placebo-tDCS) and 
on the motor function, like muscle activity (Placebo-TENS) were successful in 
inducing a reduction of the perception of physical fatigue, proving that our protocol 
was suitable to reduce physical fatigue, like other placebo studies on motor 
performance (Beedie et al., 2008; Clark et al., 2000; Pollo et al., 2008). It is also 
remarkable that not only the TENS treatment, which was applied directly to the 
hand involved in the task improved the perception of physical fatigue, but also the 
sham tDCS treatment, suggesting a potential role of the placebo sham tDCS as an 
ergogenic aid for motor performance. Sham tDCS is considered as a reliable control 
stimulation procedure since it does not induce cortical modulation and it is not 
distinguishable from active tDCS (Gandiga et al., 2006). This potential and new 
characteristic of sham tDCS in the placebo effect in the motor domain could open 
new investigations in the motor field, for instance to reduce the perception of 
physical fatigue in contexts in which movement repetition is often a requisite, like 
in motor training, motor learning and motor rehabilitation.  
Other recent studies converge in indicating that the application of sham tDCS can 
induce a placebo effect (Turi et al., 2017; Turi et al., 2018). All these evidences 
point out to the possibility of using sham tDCS during the performance of motor 
training, motor learning or motor rehabilitation protocols. This is also possible 
because tDCS can be applied in “online” mode, that is during a motor or cognitive 
task (Thair et al., 2017).   
Participants of the Placebo-tDCS group showed a significant reduction of mental 
fatigue across sessions and perceived less mental fatigue than both the Control and 
the Placebo-TENS group at the end of the experiment. This finding suggests that a 
placebo procedure that focuses on cognitive functions (increase of attention and 
concentration) can lead to a significant improvement of mental fatigue perception. 
Mental fatigue can be induced by prolonged demanding cognitive or mental 
activities (Mizuno et al., 2011; Pageaux & Lepers, 2018) and seems to have a 
relevant role in the performance of certain physical activities (MacMahon et al., 
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2014; Marcora et al., 2009; Pageaux et al., 2014; Van Cutsem et al., 2017). A 
previous study found that the decrease of performance in a time-to-exhaustion 
cycling task was due to mental fatigue (Marcora et al., 2009). In another study the 
time to complete self-paced running protocol was longer when participants reported 
mental fatigue (MacMahon et al., 2014; Pageaux et al., 2014). Previous studies on 
placebo effect in the motor domain have already shown the benefits of placebo in 
endurance exercise (Benedetti et al., 2007; Carlino et al., 2014; Carlino et al., 2016; 
Clark et al., 2000; Piedimonte et al., 2015; Pollo et al., 2008). Our study suggests 
that maybe an underlying mechanism could be found in the perception of mental 
fatigue associated with endurance exercise. 
More remarkably, scientists have shown how mental fatigue can also impair the 
performance of some motor skills or sport-technical skills (Duncan et al., 2015; 
Pageaux & Lepers, 2018; Rozand et al., 2015; Smith et al., 2016; Veness et al., 
2017). For instance, in a crossover study by Rozand et al. (2015), participants had 
to perform a task consisting of a point-to-point arm movement as fast and accurately 
as possible before and after a 90min of sustained cognitive task (experimental 
condition) or after having watched a documentary for 90min (control condition). 
Authors found that the movement was slower when subjects were mentally fatigued 
(experimental condition) than when they were not mentally fatigued (control 
condition). Moreover, Duncan et al. (2015) investigated whether the induction of 
mental fatigue could modulate the performance of a manual dexterity test in a 
crossover study. In particular, participants underwent a manual dexterity task before 
and after 40min of either a continuous cognitive task (inducing mental fatigue) or a 
passive neutral observation procedure. Authors found that after the induction of 
mental fatigue, participants needed a longer time to conclude the manual dexterity 
test (Duncan et al., 2015). The presence of mental fatigue can also have negative 
effects in sport-technical skills. For instance, mental fatigue can impair the passing 
accuracy and the speed of shooting in football players (Smith et al., 2016). These 
evidences show the potential role of mental fatigue in the performance of motor 
performance and skills. Up-to-now, no study has tackled the effect of mental fatigue 
on motor skill learning. According to the studies commented above, it is plausible 
to hypothesize that motor skills learning in which the mental demand is high (sport-
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technical skill or medical-technical skills) or the training is prolonged in time (i.e. 
massed practice in rehabilitation programs) could be affected by the presence of 
mental fatigue. In these cases, the fact that we could reduce the subjective 
perception of mental fatigue by a placebo procedure might lead us to suggest that 
the application of sham tDCS along with information on the beneficial effects on 
attention and concentration could be helpful to the performance of a motor skill 
training or motor rehabilitation program. Thus, extending the period of learning 
thanks to the reduction of mental fatigue could potentially lead to learn some skills 
or re-acquired lost movements in a shorter period of time. However, caution should 







My interest to investigate the placebo effect in the motor domain is motivated by 
my own scientific curiosity and by the potential translational impact of the motor 
placebo effect in sports and pathology. Due to the fact that very little is known about 
this phenomenon, it is mandatory to clarify some questions before moving to sport 
or clinical studies. To do so, we decided to investigate the placebo effect at two 
levels: one, regarding to the neural correlates of the placebo effect in the motor 
domain; the other referring to the type of motor functions that could be influenced 
by the placebo effect. Therefore, during the description of my thesis, I have tried to 
show to the reader the studies and experiments that we carried out to fill in the gaps 
of knowledge that were present with regards to the placebo effect in the motor 
domain at both levels. 
The neural correlates of the motor placebo effect in healthy participants have been 
related to brain areas involved in movement execution and preparation (Fiorio et 
al., 2014, Piedimonte et al., 2015). In the Part II of this thesis, we attempted to 
enlarge this knowledge by investigating the role of high-order frontal areas, like the 
dlPFC. Our finding demonstrated that active tDCS (both anodal and cathodal tDCS) 
over the left dlPFC could block the placebo-induced increase of force found in 
placebo-responders when tDCS was inactive. This effect was detected only when 
the placebo procedure consisted of expectation alone. However, tDCS showed no 
effect on the placebo-induced increase of force when a conditioning procedure was 
adopted. This finding may indicate that the left dlPFC plays a role in the motor 
placebo effect induced by verbal suggestion alone. In this study, we demonstrated 
for the first time that the left dlPFC could be involved in the expectation-induced 
enhancement of force, thus enlarging the existing knowledge on the neural 
correlates of the placebo effect in the motor domain in healthy participants. 
Regarding the behavioral investigation of the placebo effect in the motor domain, 
several studies have shown the influence of placebo on force production, movement 
speed and resistance to fatigue (Beedie et al., 2009; Fiorio et al., 2018; Pollo et al., 
2011). However, these studies were principally focussed on sport performance 
rather than motor functions present in daily life activities, like the control of balance 
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or motor sequence learning. Thus, in the Part III of the thesis, we have explored 
whether a placebo procedure could improve balance control and motor sequence 
learning in healthy participants.  
With regards to the first study in which we evaluated the effect of placebo in balance 
control, we have given the first behavioural evidence that a placebo procedure in 
the motor domain can also improve balance control and perception of stability. 
These findings could have significant translational application for clinical 
populations (like for instance Parkinson’s disease) and for the elderly, in which 
balance disturbances increase the risk of falls with a resulting negative impact on 
the quality of life. Furthermore, improving balance through a placebo procedure 
could also have a beneficial impact on gait disorders in which the pharmacological 
treatment is often not effective. In our study, we did not investigate the potential 
neural correlates of the placebo effect in balance control. Consequently, future 
neurophysiological investigations will be needed to reveal the exact mechanisms 
underpinning the placebo-induced enhancement of balance. 
On the second study performed in the Part III, we have investigated whether the 
placebo effect could modulate a motor sequence learning by two placebo 
procedures; one focused on cognitive functions, like concentration and attention 
(sham tDCS); and the other focused on the motor function, like muscle activity 
(TENS). In our experiment, we did not find higher improvement of motor sequence 
learning in neither Placebo-TENS nor Placebo-tDCS when compared to the control 
group. Remarkably, our subjective results, instead, have found a reduction of the 
perceived fatigue throughout the sessions in both placebo groups. Namely, a 
placebo procedure on the motor function (TENS) can reduce the perception of 
physical fatigue during the SRTT. Interestingly, a placebo procedure addressing the 
cognitive function (sham tDCS) can decrease not only the perception of physical 
fatigue, but also of mental fatigue. The fact that this placebo procedure (sham tDCS) 
has demonstrated its relevant role in reducing both fatigue perception (mental and 
physical) in a motor sequence learning task, opens the possibility to explore new 
strategies to investigate the placebo effect in the motor domain. Specifically, sham 
tDCS could be applied as an “online” placebo treatment and be implemented in 
motor training or motor rehabilitation as well. Further studies on consolidation or 
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longer period of motor skill learning should be conducted to gain a better 
understanding of these effects. 
To summarize, we have been able to expand the actual knowledge about the placebo 
effect in the motor domain regarding both levels of study, the neural correlates and 
the behavioral influences of this phenomenon, thus, showing that the left dlPFC 
could be involved in the placebo effect in the motor domain, particularly when the 
placebo effect is induced by verbal suggestion alone. Moreover, the control of 
balance could be modulated by the induction of positive expectation through verbal 
suggestion. Lastly, a placebo procedure focused on cognitive function could reduce 
the perception of both mental and physical fatigue in a repetitive motor task.  
Although we have contributed to enlarge the knowledge about the placebo effect in 
the motor domain, many questions remain unanswered. Thus, further studies should 
be performed to unveil the mechanisms of the placebo effect in the motor domain, 
not only in healthy population, but also in people affected by movement or gait 
disorders, in which the placebo effect could potentially improve motor performance 
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